EP2220204B1 - Washing agent having stabilized enzymes - Google Patents

Washing agent having stabilized enzymes Download PDF

Info

Publication number
EP2220204B1
EP2220204B1 EP08853177.7A EP08853177A EP2220204B1 EP 2220204 B1 EP2220204 B1 EP 2220204B1 EP 08853177 A EP08853177 A EP 08853177A EP 2220204 B1 EP2220204 B1 EP 2220204B1
Authority
EP
European Patent Office
Prior art keywords
protease
enzyme
washing
cleaning agent
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP08853177.7A
Other languages
German (de)
French (fr)
Other versions
EP2220204A1 (en
Inventor
Robin Ghosh
Andreas Michels
Cornelius Bessler
Daniela Lowis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2220204A1 publication Critical patent/EP2220204A1/en
Application granted granted Critical
Publication of EP2220204B1 publication Critical patent/EP2220204B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38663Stabilised liquid enzyme compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/36Organic compounds containing phosphorus
    • C11D3/362Phosphates or phosphites
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase

Definitions

  • the present application relates to detergents and cleaners containing phosphate compounds having aliphatic and / or aromatic radicals which act as enzyme stabilizers.
  • enzymes in detergents and cleaners serve to extend the range of services of the funds concerned according to their specific activities. These include in particular hydrolytic enzymes such as proteases, amylases, lipases and cellulases. The first three hydrolyze proteins, starches and fats and thus contribute directly to soil removal. Cellulases are used in particular because of their tissue effect.
  • Another group of washing and cleaning agent enzymes are oxidative enzymes, in particular oxidases, which, if appropriate, in combination with other components, are preferably used to bleach soiling or to produce the bleaching agents in situ.
  • enzymes which are subjected to constant optimization, further enzymes are constantly being made available for use in detergents and cleaners in order to be able to optimally address particular soiling, such as pectinases, ⁇ -glucanases, mannanases or other hemicellulases for hydrolysis, in particular more specific vegetable polymers.
  • proteases and in particular serine proteases, which include the subtilases. They cause the degradation of protein-containing stains on the items to be cleaned. However, they also hydrolyze themselves (autoproteolysis) and all other proteins contained in the agents concerned, i. especially other enzymes. This happens especially during the cleaning process, i. in the aqueous wash liquor, if comparatively favorable reaction conditions are present. However, this also happens during the storage of the respective agent, which is why with increasing storage time always a certain loss of enzyme activities, such as the protease activity, accompanied.
  • the enzyme activity in the washing or cleaning agent is inversely proportional to the storage time, with increasing storage time, the enzyme activity decreases more and more. This is particularly problematic in gel or liquid and in particular in water-containing formulations, because in this with the water contained both the reaction medium and the hydrolysis reagent are available.
  • One goal in the development of detergents and cleaners is therefore to stabilize the enzymes contained, especially during storage.
  • the protection understood against various unfavorable influences such as against denaturation or decay by physical influences or oxidation.
  • One focus of these developments is the protection of the contained proteins and / or enzymes against proteolytic cleavage. This can be done by the construction of physical barriers, such as by encapsulation of the enzymes in special enzyme granules or by packaging the means in two- or multi-chamber systems.
  • Another frequently approached approach is to add chemical compounds to the agents which inhibit the proteases and thus act collectively as stabilizers for the proteases and the other proteins and enzymes contained. It must be reversible protease inhibitors, since the protease activity is only temporarily, especially during storage, but not be suppressed during the cleaning process.
  • Polyols in particular glycerol and 1,2-propylene glycol, benzamidine hydrochloride, borax, boric acids, boronic acids or their salts or esters are established as reversible protease inhibitors in the prior art.
  • These include, in particular, derivatives with aromatic groups, for example ortho, meta or para-substituted phenylboronic acids, in particular 4-formylphenylboronic acid (4-FPBA) or the salts or esters of the abovementioned compounds.
  • 4-FPBA 4-formylphenylboronic acid
  • peptide aldehydes that is oligopeptides with reduced C-terminus, especially those of 2 to 50 monomers, are described for this purpose.
  • peptidic reversible protease inhibitors include ovomucoid and leupeptin.
  • specific, reversible peptide inhibitors and fusion proteins from proteases and specific peptide inhibitors are used for this purpose.
  • polyols such as glycerol and 1,2-propylene glycol have proved to be unfavorable due to their high necessary use concentrations, because the other active ingredients of the respective agents can thus be contained only in proportionally smaller proportions.
  • Boric acid derivatives occupy an outstanding position among the serine protease inhibitors, which are effective at comparatively low concentrations.
  • the international patent application discloses WO 96/21716 A1 that boric acid derivatives acting as protease inhibitors are also suitable for stabilizing enzymes in detergents and cleaners.
  • a selection of particularly powerful stabilizers are disclosed in the international patent application WO 96/41859 A1 ,
  • boric acid derivatives have a decisive disadvantage.
  • Another object of the present invention is to provide boron-free chemical compounds which act as protease inhibitors and are thus suitable as stabilizers for proteases and / or for other enzymes in detergents and cleaners.
  • a washing or cleaning agent should be provided with such a boron-free chemical compound.
  • An object of the invention is a washing or cleaning agent containing an enzyme and a compound of the general structural formula wherein X is an aliphatic or an aromatic radical and Y is an aliphatic or an aromatic radical, wherein the radical X is selected from the group consisting of -CH 2 -CH 2 -CH 3 , phenyl.
  • the washing or cleaning agent is characterized in that the radicals X and Y of the compound are identical, wherein the radical X is selected from the group consisting of: -CH 2 CH 2 CH 3 , phenyl, and the Rest Y as well is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl.
  • a particularly preferred compound therefore has as radical X and as radical Y a: -CH 2 -CH 2 -CH 3 - group.
  • a further particularly preferred compound accordingly has as radical X and as radical Y a phenyl group.
  • a detergent or cleaning agent according to the invention are all means that are suitable for washing or cleaning of particular textiles and / or solid surfaces.
  • an enzyme is to be understood as meaning a protein which has a specific biocatalytic function.
  • protease is understood as meaning an enzyme which catalyzes the hydrolysis of peptide bonds and is thereby able to cleave peptides or proteins.
  • the present invention encompasses the compounds mentioned in all protonated and / or deprotonated forms.
  • oppositely charged cations H + , Na + , K + or the like
  • anions Cl - , Br - , formate, acetate, etc.
  • the present invention can be realized. Decisive in each case is the interaction between the invention-relevant compound which stabilizes the enzyme and the enzyme to be stabilized according to the invention.
  • the compounds relevant for the invention ie the stabilizing compounds
  • form a complex with the enzyme to be stabilized It is anticipated that non-covalent binding of the stabilizing compound will occur in or at the substrate binding pocket of the enzyme. In this way, the active site of the enzyme is blocked by a compound which is not hydrolyzable by this enzyme and is therefore no longer available for the catalysis of other substrates present.
  • the stabilizing effect of the compound is therefore due to an inhibition of the enzyme. This is a reversible bond, ie a balance between association and dissociation.
  • the equilibrium coefficient of this reaction is called the inhibition constant or K i .
  • the enzyme Due to the reversible binding of the stabilizing compound to the enzyme, the enzyme is inhibited and thus stabilized in the washing or cleaning agent, whereas the complexes are increasingly dissociated by the changed conditions when using the detergent and cleaning agent, for example by dilution of the detergent Washing or cleaning agent in the washing or cleaning solution, by the presence of further and / or higher affinity enzyme substrates or by changing the pH in the washing or cleaning solution.
  • stabilizing and “inhibiting” or “inhibiting” as well as “stabilizer” and “inhibitor” or “inhibitor” are therefore to be regarded as synonymous in the present patent application.
  • a further subject of the invention is a washing or cleaning agent which is characterized in that the compound has an inhibition constant with respect to the enzyme. K i ) of 0.01 to 10 mM.
  • the washing or cleaning agent is characterized in that the stabilizing compound has an inhibition constant (K i ) of 0.03 to 5 mM with respect to the enzyme.
  • [E], [I] and [EI] represent the respective molar equilibrium concentrations of enzyme (E), inhibitor (I) and the enzyme-inhibitor complex (EI). According to this definition, a substance with a small K i is a good inhibitor under the respective test conditions.
  • K i The determination of K i is carried out on the basis of the activity test of the protease in the presence of the corresponding inhibitor.
  • the kinetics of invertin action, Biochem. Z. 49: 333-369 ), the enzymatic parameters K m , and k cat are determined in the presence of various concentrations of the inhibitor.
  • Vmax the maximum reaction rate at substrate saturation
  • K i can be calculated using the Cheng-Prusoff equation ( Equation 2, Cheng Y., Prusoff WH (1973) Biochem. Pharmacol. 22, 3099-3108 ) are determined via the IC 50 value.
  • the determination of the IC 50 via the determination of the catalytic activity to a substrate in the presence of various concentrations of the inhibitor and the fitting of the experimental data to a sigmoidal dose-response with variable slope equation (pseudo-Hill slopes). It is the inhibitor concentration needed to achieve 50% inhibition.
  • K i IC 50 / 1 + S / K d
  • [S] is the substrate concentration in the assay and K d is the dissociation constant for the substrate, which at the IC 50 concentration of the inhibitor can be considered to be identical to K m for the substrate.
  • the K i values that can be determined in this way characterize the compound with respect to the enzyme used.
  • a protease namely the Bacillus lentus alkaline protease F49 (according to WO 95/23221 A1 ) in the presence of an inhibitor. Since this is a typical subtilisin protease, the values obtained with this enzyme are also typical of other serine proteases, in particular other subtilisin proteases. The exact value for an enzyme of interest must be determined in case of doubt based on the specific enzyme.
  • an advantage of the compounds according to the invention which effect the stabilization of at least one enzyme in detergents and cleaners is that they have favorable inhibition constants with respect to the enzymes to be used in detergents and cleaning agents compared with the prior art. This is especially true for proteases, but also for other enzymes. A largely reversible binding of the inhibitors is thus ensured, ie they do not enter into solid and not too loose transient interactions with the enzyme.
  • the majority of the enzymes are thus present in the form of an enzyme-inhibitor complex during storage of the detergents and cleaners.
  • the enzymes, in particular proteases, and optionally other proteins present are protected in this way, for example against catalytic, in particular hydrolytic activities of these enzymes themselves.
  • the compounds relevant to the invention are functional enzyme inhibitors according to the task formulated and thus enzyme stabilizers for detergents and cleaners.
  • compounds according to the invention have a low volume requirement in comparison with established prior art enzyme stabilizers, for example with respect to polyols.
  • Another advantage of the invention relevant compounds over the prior art is that they have as elements only carbon (C), hydrogen (H), phosphorus (P) and oxygen (O) and in particular are free of boron. Thus, they do not form the undesirable boron-derived by-products with other detergent or cleaning ingredients.
  • the compounds mentioned are presumed to act as reversible inhibitors because they structurally resemble the substrate of the enzymes, concerning proteases, in particular with regard to the acid amide bond to be hydrolyzed.
  • the enzymes preferably proteolytic enzymes, can thus be inhibited by the compounds relevant to the invention. This applies in particular to serine proteases, as shown by the examples of the present application with the positive effect of the described compounds on the basis of subtilisins.
  • the enzyme is in particular in a content of 2 .mu.g to 20 mg per g of the composition, preferably from 5 ⁇ g to 17.5 mg per g of the agent, more preferably from 20 ⁇ g to 15 mg per g of the agent, most preferably from 50 ⁇ g to 10 ⁇ g of the agent.
  • the compound, ie the stabilizer is contained in agents according to the invention in particular in a content of up to 50 mg per g of the agent, preferably up to 10 mg, more preferably up to 7 mg, very particularly preferably up to 5 mg per g of the agent. Furthermore, it is preferred that the amount of the compound contained in the agent, ie the stabilizing the enzyme Compound, based on the stabilized enzyme of 0.01 to 100 x the inhibition constant K i , preferably 0.1 to 10 x K i , more preferably 1 to 5 x K i .
  • the molar ratio of the stabilizing compound to the enzyme is preferably 1: 1 to 1000: 1, in particular from 1: 1 to 500: 1, particularly preferably from 1: 1 to 100: 1, very particularly preferably from 1: 1 1 to 20: 1.
  • Another object of the invention are detergents or cleaners characterized in that the enzyme is selected from the group consisting of: protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, ⁇ -glucosidase, carrageenase, oxidase, Oxidoreductase, lipase, esterase or mixtures thereof.
  • the washing or cleaning agent is characterized in that the enzyme is a protease, preferably a serine protease, more preferably a subtilase and most preferably a subtilisin.
  • proteolytic enzymes due to their enzymatic activity, proteolytic enzymes lead to the hydrolysis of proteins, such as enzymes and peptides, which are contained in the composition, be it other proteins or enzymes or also the proteases themselves. Hydrolysis of the protease by its own proteolytic activity becomes referred to as autoproteolysis.
  • the degree of storage stability of all proteins / enzymes contained in a protein / enzyme composition is thus dependent, in particular, on the proteolytic activity of a protease within this composition.
  • subtilisins BPN 'and Carlsberg examples of such proteases are the subtilisins BPN 'and Carlsberg, the protease PB92, the subtilisins 147 and 309, the alkaline protease from Bacillus lentus, subtilisin DY and the enzymes thermitase, proteinase K which can no longer be assigned to the subtilisins in the narrower sense and the proteases TW3 and TW7.
  • Subtilisin Carlsberg is available in a further developed form under the trade name Alcalase® from Novozymes A / S, Bagsv ⁇ rd, Denmark.
  • the subtilisins 147 and 309 are sold under the trade names Esperase®, and Savinase® by the company Novozymes. From the protease from Bacillus lentus DSM 5483 derived under the name BLAP® protease variants derived.
  • proteases are, for example, under the trade names Durazym ®, relase ®, Everlase® ®, Nafizym, Natalase ®, Kannase® ® and Ovozymes ® from Novozymes, under the trade names Purafect ®, Purafect ® OxP and Properase.RTM ® from Genencor , under the trade name Protosol® ® from Advanced Biochemicals Ltd., Thane, India, under the trade name Wuxi ® from Wuxi Snyder Bioproducts Ltd., China, under the trade names Proleather® ® and protease P ® from Amano Pharmaceuticals Ltd., Nagoya, Japan, and the enzyme available under the name Proteinase K-16 from Kao Corp., Tokyo, Japan.
  • proteases are particularly well stabilized or reversibly inhibited by the compounds described.
  • certain variants of proteases i. also variants of said proteases, stabilized by these compounds particularly advantageous.
  • Such protease variants are part of the invention described below.
  • a protease stabilized or reversibly inhibited according to the invention can be a wild-type enzyme or a protease variant.
  • wild-type enzyme is to be understood that the enzyme is present in a naturally occurring organism or in a natural habitat can be isolated from this.
  • enzymes are modifiable and sometimes selectively modified, in particular in order to adapt their properties to the intended uses or to influence their catalytic activity. These changes often occur by altering the amino acid sequence of the enzyme. Such changes can be targeted and thus local or random, for example, by random mutagenesis done.
  • An enzyme variant is understood as meaning enzymes which have been generated from an initial enzyme, for example a wild-type enzyme, by altering the amino acid sequence.
  • the alteration of the amino acid sequence is preferably carried out by mutations, wherein amino acid substitutions, deletions, insertions or combinations thereof may be made.
  • the incorporation of such mutations into proteins is well known in the art and to those skilled in the art of enzyme technology. In principle, all enzymes can be changed in this way.
  • Protease variants are preferred according to the invention. These were generated from an initial protease, for example a wild-type protease, by altering the amino acid sequence, preferably amino acid substitutions, deletions, insertions or combinations thereof.
  • the starting protease does not necessarily have to be a naturally occurring wild-type protease; a protease known from the prior art in which changes have already been made can also be further developed and therefore again serve as an initial protease for generating further protease variants.
  • proteases described above may be used unchanged in agents according to the invention and be stabilized by the compounds described. However, they can also be the starting enzyme for a variant which is then contained in an agent according to the invention and stabilized by the compounds described.
  • the washing or cleaning agent is therefore characterized in that the protease was obtained from an initial protease by at least one change of an amino acid, the change being a substitution, insertion or deletion of an amino acid, and adding it to the parent protease Amino acid level is at least 90%, preferably at least 92.5%, more preferably at least 95% and most preferably at least 97.5% identical.
  • sequence comparisons are known to the person skilled in the art of enzyme technology.
  • sequence comparisons for example, the identity or homology values are determined for sequences to be compared.
  • Such a comparison is accomplished by associating similar sequences in the nucleotide or amino acid sequences of the proteins of interest. This is called homologization.
  • a tabular assignment of the respective positions is referred to as alignment.
  • alignments are created using computer programs, such as the algorithms FASTA or BLAST; This procedure is for example by DJ Lipman and WR Pearson (1985) in Science, Vol. 227, pp. 1435-1441 described.
  • a summary of all matching positions in the compared sequences is called a consensus sequence.
  • Such a comparison also allows a statement about the similarity or homology of the compared sequences to each other. This is represented in percent identity, that is the proportion of identical nucleotides or amino acid residues at the same or in an alignment corresponding positions. A broader concept of homology includes the conserved amino acid substitutions in this value. It then speaks of percent similarity. Such statements can be made about whole proteins or genes or only over individual areas.
  • homologous regions of different proteins are defined by matches in amino acid sequence. These can also be identified by identical function. It goes as far as complete identities in the smallest areas, so-called boxes, which contain only a few amino acids and usually perform essential functions for the overall activity.
  • the functions of the homologous regions are to be understood as the smallest partial functions of the function carried out by the entire protein, such as, for example, the formation of individual hydrogen bonds for the complexation of a substrate or transition complex.
  • sequence comparisons or alignments also serve to determine mutually corresponding positions in different molecules.
  • positions in the respective amino acid or nucleic acid sequence correspond to one another, even if the respective sequences have, for example, different total lengths or different domains or partial sequences or if additional amino acids or nucleotides are present within a sequence are.
  • a specific position in a first sequence can therefore be concretely assigned to a corresponding position in a second sequence, whereby it is quite possible for the positions corresponding to one another to be located at different locations in the molecule.
  • different amino acid residues may be present at the corresponding positions. Therefore, for such sequence comparisons or for the determination Specifically specified a position, which position it is and which enzyme is assumed, that is, which counting method of determining position is to be based.
  • the amino acid sequence of the mature protein of the alkaline protease from Bacillus lentus DSM 5483 is used for determining the position, which is described in International Published Patent Application WO 91/02792 A1 and has a length of 269 amino acid residues (referred to in the present application as Bacillus lentus alkaline protease).
  • the washing or cleaning agent is characterized in that the protease was obtained from an initial protease by at least one change of an amino acid, the change being a substitution or insertion of an amino acid in that region of the amino acid sequence corresponding to the positions 95 to 103 of the alkaline protease from Bacillus lentus is assigned in an alignment.
  • Such a protease variant is particularly preferably a variant with an insertion of a single amino acid according to one or more of the positions 95, 96, 97, 98, 99, 100, 101, 102 and / or 103 and very particularly preferably between positions 97 and 98 and / or positions 99 and 100.
  • the washing or cleaning agent is characterized in that the protease has been obtained from an initial protease by at least one modification of an amino acid which corresponds to the positions 3, 4, 36, 42, 43, 47, 56, 61, 69 , 87, 96, 99, 101, 102, 104, 114, 118, 120, 130, 139, 141, 142, 154, 157, 188, 193, 199, 205, 211, 224, 229, 236, 237, 242 , 243, 250, 253, 255 and 268 of the Bacillus lentus alkaline protease in an alignment, wherein the alteration is a substitution, insertion or deletion of an amino acid.
  • an amino acid change relative to the parent molecule occurs in one or more of the following positions: 3, 4, 43, 61, 188, 193, 199, 211, 224, 250 and 253 (count according to Bacillus lentus alkaline protease), more preferably with one or more of the amino acid substitutions X3T, X4I, X43V, X61A, X188P, X193M, X199I, X211L, X211D, X211E, X211G, X211N or X211Q, X224V, X250G and / or X253N.
  • the protease is a variant with a point mutation in position 211, preferably with a substitution of a single amino acid in this position, particularly preferably with the amino acid substitution X211 L.
  • the above position information relate turn to those amino acid residues that are assigned to the said positions of the alkaline protease from Bacillus lentus in an alignment.
  • Detergents or cleaning agents according to the invention may contain only one enzyme. Alternatively, they may also contain other enzymes in a concentration effective for the effectiveness of the agent.
  • a further subject of the invention thus represents agents which further comprise one or more further enzymes, wherein in principle all enzymes established in the prior art for these purposes can be used.
  • enzymes which can be used as further enzymes are all enzymes which can develop catalytic activity in the agent according to the invention, in particular proteases, amylases, cellulases, hemicellulases, mannanases, tannases, xylanases, xanthanases, ⁇ -glucosidases, carrageenases, oxidases, oxidoreductases, lipases or esterases and preferably mixtures thereof.
  • the cellulase is preferably a cellulase mixture or a one-component cellulase, preferably or predominantly an endoglucanase and / or a cellobiohydrolase.
  • the oxidoreductase is preferably an oxidase, in particular a choline oxidase, or a perhydrolase.
  • Agents according to the invention preferably contain enzymes in total amounts of 1 ⁇ 10 -8 to 5 percent by weight, based on active protein.
  • the enzymes are from 0.001 to 5% by weight, more preferably from 0.01 to 5% by weight, even more preferably from 0.05 to 4% by weight and most preferably from 0.075 to 3.5% by weight.
  • the protein concentration can be determined by known methods, for example the BCA method (bicinchoninic acid, 2,2'-biquinolyl-4,4'-dicarboxylic acid) or the biuret method ( Gornall AG, CS Bardawill and MM David, J. Biol. Chem., 177 (1948), pp. 751-766 ).
  • the further enzymes particularly preferably support the effect of the agent, for example the cleaning performance of a washing or cleaning agent, with regard to certain stains or stains.
  • the enzymes show synergistic effects with respect to their action against certain stains or stains, ie the enzymes contained in the middle composition mutually support each other in their cleaning performance. Synergistic effects can occur not only between different enzymes, but also between one or more enzymes and other ingredients of the composition according to the invention.
  • the enzymes used in agents of the invention are either originally from microorganisms, such as the genera Bacillus, Streptomyces, Humicola, or Pseudomonas, and / or are produced by biotechnological methods known per se by suitable microorganisms, for example by transgenic expression hosts of the genera Bacillus or by filamentous fungi ,
  • the enzyme (s) and the stabilizing compound are preferably combined with one or more of the following ingredients: nonionic, anionic and / or cationic surfactants, bleaches, bleach activators, bleach catalysts, builders and / or cobuilders, acids, alkaline substances, Hydrotropes, solvents, thickeners, sequestering agents, electrolytes, optical brighteners, grayness inhibitors, corrosion inhibitors, in particular silver protectants (silver corrosion inhibitors), soil release agents, color transfer (or transfer) inhibitors, foam inhibitors, abrasives, dyes, fragrances, perfumes, antimicrobial agents, UV protectants or absorbents, antistatic agents, pearlescing agents and skin protection agents, further stabilizers, in particular enzyme stabilizers, and other components known from the prior art.
  • a further subject of the invention therefore is washing or cleaning agents which are characterized in that they contain at least one further component which is selected from the group consisting of surfactants, builders, acids, alkaline substances, hydrotropes, solvents, thickeners, bleaching agents, Dyes, perfumes, corrosion inhibitors, sequestering agents, electrolytes, optical brighteners, grayness inhibitors, silver corrosion inhibitors, dye transfer inhibitors, foam inhibitors, abrasives, UV absorbers, solvents, antistatic agents, pearlescers and skin protection agents.
  • surfactants builders, acids, alkaline substances, hydrotropes, solvents, thickeners, bleaching agents, Dyes, perfumes, corrosion inhibitors, sequestering agents, electrolytes, optical brighteners, grayness inhibitors, silver corrosion inhibitors, dye transfer inhibitors, foam inhibitors, abrasives, UV absorbers, solvents, antistatic agents, pearlescers and skin protection agents.
  • Agents according to the invention preferably comprise at least one complexing agent and / or builder substances, the builder being in particular a zeolite builder, and / or a nonionic surfactant, the nonionic surfactant preferably being a hydroxy mixed ether, and / or optical Brightener, wherein the optical brightener is diphenyl compounds, in particular distyryl biphenyl derivatives, and / or stilbentriazine derivatives.
  • the ingredients to be selected as well as the conditions under which the agent is used should be optimized for the respective cleaning problem.
  • the usual temperatures for detergents and cleaners in the range of 10 ° C for manual agents over 20 ° C, 30 ° C, 40 ° C and 60 ° C up to 95 ° for mechanical means or in technical applications. Since the temperature is usually infinitely adjustable in modern washing machines and dishwashers, all intermediate stages of the temperature are included.
  • the ingredients of the respective agents are coordinated. Synergies are preferred in terms of cleaning performance. Particularly preferred in this regard are synergies which are present in a temperature range between 20.degree. C. and 60.degree. C., since the enzyme or the enzymes contained in the agents according to the invention are also catalytically active in this temperature range.
  • the washing or cleaning agent is characterized in that it contains at least one further stabilizer.
  • the stabilizer (s) is one or more polyols, in particular glycerol or 1,2-ethylene glycol, an antioxidant, lactate or one or more lactate derivatives or combinations thereof. It is likewise preferably one or more of those enzyme-stabilizing or inhibiting compounds which are described in the international patent applications WO 07/113241 A1 or WO 02/008398 are disclosed.
  • Another object of the invention is the use of a compound of the general structural formula wherein X is an aliphatic or an aromatic radical and Y is an aliphatic or an aromatic radical, as a reversible inhibitor of an enzyme in a washing or cleaning agent. Because, as already stated above, cause these compounds due to their mechanism of action as a reversible inhibitor advantageous stabilization of the enzyme in the washing or cleaning agent.
  • the use is characterized in that the radicals X and Y are identical.
  • the radical X is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl.
  • the radical Y is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl.
  • the enzyme is selected from the group consisting of: protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, ⁇ -glucosidase, carrageenase, oxidase, Oxidoreductase, lipase, esterase or mixtures thereof.
  • the enzyme is particularly preferably a protease, preferably a serine protease, more preferably a subtilase and particularly preferably a subtilisin.
  • Another object of the invention is therefore the use of an enzyme and a compound of the general structural formula wherein X is an aliphatic or an aromatic radical and Y is an aliphatic or an aromatic radical, for the preparation of a washing or cleaning agent.
  • the compound is one in which the radicals X and Y are identical and / or the radical X is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl, and / or the Rest Y is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl.
  • this invention is characterized in that the enzyme is selected from the group consisting of: protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, ⁇ -glucosidase, carrageenase, oxidase, oxidoreductase, lipase, esterase or mixtures thereof.
  • the enzyme is particularly preferably a protease, preferably a serine protease, more preferably a subtilase and particularly preferably a subtilisin.
  • Another object of the invention is a washing or cleaning process in which an enzyme acts, which is inhibited and / or stabilized with a compound of the general structural formula wherein X is an aliphatic or an aromatic radical and Y is an aliphatic or an aromatic radical.
  • the compound is one in which the radicals X and Y are identical and / or the radical X is selected from the group consisting of: CH 2 -CH 2 -CH 3 , phenyl, and / or the radical Y is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl.
  • these compounds cause due to their mechanism of action as a reversible inhibitor advantageous stabilization of the enzyme in the washing or cleaning agent, so that for the washing or cleaning process, a higher enzyme activity is available in comparison with a detergent or cleaning agent in which the enzyme was not stabilized.
  • this subject matter of the invention is characterized in that the enzyme is selected from the group consisting of: protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, ⁇ -glucosidase, carrageenase, oxidase, oxidoreductase, lipase, Esterase or mixtures thereof.
  • the enzyme is particularly preferably a protease, preferably a serine protease, more preferably a subtilase and particularly preferably a subtilisin.
  • the washing or cleaning method is further characterized in that a washing or cleaning agent according to the invention is used, as described above.
  • washing or cleaning agents according to the invention can advantageously be used for cleaning purposes.
  • a further subject of the invention is therefore the use of a washing or cleaning agent, as described above, for washing and / or cleaning textiles and / or hard surfaces.
  • the compounds resulted in a residual activity of the protease of less than 60%.
  • V1 is the strongest and thus most suitable protease inhibitor or stabilizer, followed by V2.
  • the residual activities of the protease were 45% for V1 and 56% for V2.
  • a liquid detergent was prepared with the following composition (all figures in percent by weight): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7% glycerol, 0.3 -0.5% ethanol, 4-7% FAEOS, 24-28% nonionic surfactants, 1% boric acid, 1-2% sodium citrate (dihydrate), 2-4% soda, 14-16% coconut fatty acids, 0.5 % HEDP, 0-0.4% PVP, 0-0.05% optical brightener, 0-0.001% dye, balance: demineralized water.
  • This formulation was admixed with the inhibiting compounds of Example 1 to be tested and 1,275,000 HPE / I B. lentus alkaline protease F 49.
  • the protease activity (Henkel protease units) reported in HPE was calculated after van Raay, Saran and Verbeek, according to the publication " For the determination of the proteolytic activity in enzyme concentrates and enzyme-containing detergents, dishwashing detergents and cleaners "in Tenside (1970), Volume 7, pp. 125-132 , certainly.
  • the initial values for the proteolytic activity of the agent in question were compared with the values determined after storage. The higher the activity remaining after storage, the better the protease contained was inactivated during storage and the better the compound in question is suitable as a stabilizer according to the invention.

Abstract

The present application relates to washing and cleaning agents, containing phosphate compounds having aliphatic and/or aromatic residues, which act as enzyme stabilizers. Further subjects are the use of such compounds as reversible inhibitors of enzymes, in particular of proteolytic enzymes, and thus as stabilizers in washing or cleaning agents, and further methods and uses correlated therewith.

Description

Die vorliegende Anmeldung betrifft Wasch- und Reinigungsmittel enthaltend Phosphatverbindungen mit aliphatischen und/oder aromatischen Resten, die als Enzymstabilisatoren wirken.The present application relates to detergents and cleaners containing phosphate compounds having aliphatic and / or aromatic radicals which act as enzyme stabilizers.

Der Einsatz von Enzymen in Wasch- und Reinigungsmitteln ist im Stand der Technik etabliert. Sie dienen dazu, das Leistungsspektrum der betreffenden Mittel entsprechend ihren speziellen Aktivitäten zu erweitern. Hierzu gehören insbesondere hydrolytische Enzyme wie Proteasen, Amylasen, Lipasen und Cellulasen. Die ersten drei genannten hydrolysieren Proteine, Stärke und Fette und tragen somit unmittelbar zur Schmutzentfernung bei. Cellulasen werden insbesondere wegen ihrer Gewebewirkung eingesetzt. Eine weitere Gruppe von Wasch- und Reinigungsmittelenzymen sind oxidative Enzyme, insbesondere Oxidasen, die ggf. im Zusammenspiel mit anderen Komponenten vorzugsweise dazu dienen, Anschmutzungen zu bleichen oder die bleichenden Agentien in situ zu erzeugen. Neben diesen Enzymen, die einer fortwährenden Optimierung unterworfen werden, werden laufend weitere Enzyme für den Einsatz in Wasch- und Reinigungsmitteln bereitgestellt, um insbesondere spezielle Anschmutzungen optimal angehen zu können, wie beispielsweise Pektinasen, β-Glucanasen, Mannanasen oder weitere Hemicellulasen zur Hydrolyse insbesondere spezieller pflanzlicher Polymere.The use of enzymes in detergents and cleaners is well established in the art. They serve to extend the range of services of the funds concerned according to their specific activities. These include in particular hydrolytic enzymes such as proteases, amylases, lipases and cellulases. The first three hydrolyze proteins, starches and fats and thus contribute directly to soil removal. Cellulases are used in particular because of their tissue effect. Another group of washing and cleaning agent enzymes are oxidative enzymes, in particular oxidases, which, if appropriate, in combination with other components, are preferably used to bleach soiling or to produce the bleaching agents in situ. In addition to these enzymes, which are subjected to constant optimization, further enzymes are constantly being made available for use in detergents and cleaners in order to be able to optimally address particular soiling, such as pectinases, β-glucanases, mannanases or other hemicellulases for hydrolysis, in particular more specific vegetable polymers.

Die am längsten etablierten und in praktisch allen modernen, leistungsfähigen Wasch- und Reinigungsmitteln enthaltenen Enzyme sind Proteasen und hierunter insbesondere Serin-Proteasen, zu denen auch die Subtilasen zählen. Sie bewirken den Abbau proteinhaltiger Anschmutzungen auf dem Reinigungsgut. Allerdings hydrolysieren sie auch sich selbst (Autoproteolyse) und alle anderen in den betreffenden Mitteln enthaltenen Proteine, d.h. insbesondere auch weitere Enzyme. Dies geschieht besonders während des Reinigungsvorgangs, d.h. in der wässrigen Waschflotte, wenn vergleichsweise günstige Reaktionsbedingungen vorliegen. Dies geschieht aber auch während der Lagerung der betreffenden Mittel, weshalb mit zunehmender Lagerdauer immer auch ein gewisser Verlust von Enzymaktivitäten, beispielsweise der Proteaseaktivität, einhergeht. In der Regel ist die Enzymaktivität in dem Wasch- oder Reinigungsmittel umgekehrt proportional zur Lagerdauer, mit fortschreitender Lagerdauer nimmt die Enzymaktivität immer weiter ab. Besonders problematisch ist dies in gelförmigen oder flüssigen und insbesondere in wasserhaltigen Rezepturen, weil in diesem mit dem enthaltenen Wasser sowohl das Reaktionsmedium als auch das Hydrolyse-Reagenz zur Verfügung stehen.The enzymes that have long been established and are contained in virtually all modern, high-performance detergents and cleaners are proteases, and in particular serine proteases, which include the subtilases. They cause the degradation of protein-containing stains on the items to be cleaned. However, they also hydrolyze themselves (autoproteolysis) and all other proteins contained in the agents concerned, i. especially other enzymes. This happens especially during the cleaning process, i. in the aqueous wash liquor, if comparatively favorable reaction conditions are present. However, this also happens during the storage of the respective agent, which is why with increasing storage time always a certain loss of enzyme activities, such as the protease activity, accompanied. In general, the enzyme activity in the washing or cleaning agent is inversely proportional to the storage time, with increasing storage time, the enzyme activity decreases more and more. This is particularly problematic in gel or liquid and in particular in water-containing formulations, because in this with the water contained both the reaction medium and the hydrolysis reagent are available.

Ein Ziel bei der Entwicklung von Wasch- und Reinigungsmitteln besteht somit darin, die enthaltenen Enzyme besonders während der Lagerung zu stabilisieren. Darunter wird der Schutz gegen verschiedene ungünstige Einflüsse verstanden, wie beispielsweise gegen Denaturierung oder Zerfall durch physikalische Einflüsse oder Oxidation. Ein Schwerpunkt dieser Entwicklungen besteht im Schutz der enthaltenen Proteine und/oder Enzyme gegen proteolytische Spaltung. Diese kann durch den Aufbau physikalischer Barrieren erfolgen, etwa durch Verkapselung der Enzyme in speziellen Enzymgranulaten oder durch Konfektionierung der Mittel in Zwei- oder Mehrkammersystemen. Ein anderer vielfach beschrittener Weg besteht darin, den Mitteln chemische Verbindungen zuzusetzen, die die Proteasen inhibieren und somit insgesamt als Stabilisatoren für die Proteasen und die anderen enthaltenen Proteine und Enzyme wirken. Es muss sich dabei um reversible Proteaseinhibitoren handeln, da die Proteaseaktivität nur vorübergehend, insbesondere während der Lagerung, nicht aber mehr während des Reinigungsprozesses unterbunden werden soll.One goal in the development of detergents and cleaners is therefore to stabilize the enzymes contained, especially during storage. Below that is the protection understood against various unfavorable influences, such as against denaturation or decay by physical influences or oxidation. One focus of these developments is the protection of the contained proteins and / or enzymes against proteolytic cleavage. This can be done by the construction of physical barriers, such as by encapsulation of the enzymes in special enzyme granules or by packaging the means in two- or multi-chamber systems. Another frequently approached approach is to add chemical compounds to the agents which inhibit the proteases and thus act collectively as stabilizers for the proteases and the other proteins and enzymes contained. It must be reversible protease inhibitors, since the protease activity is only temporarily, especially during storage, but not be suppressed during the cleaning process.

Als reversible Proteaseinhibitoren sind im Stand der Technik Polyole, insbesondere Glycerin und 1,2-Propylenglycol, Benzamidin-Hydrochlorid, Borax, Borsäuren, Boronsäuren oder deren Salze oder Ester etabliert. Darunter sind vor allem Derivate mit aromatischen Gruppen, etwa ortho-, meta- oder para-substituierte Phenylboronsäuren zu erwähnen, insbesondere 4-Formylphenyl-Boronsäure (4-FPBA) beziehungsweise die Salze oder Ester der genannten Verbindungen. Ein besonders guter Schutz ergibt sich, wenn Borsäurederivate zusammen mit Polyolen eingesetzt werden, da sie dann einen das Enzym stabilisierenden Komplex bilden können. Auch Peptidaldehyde, das heißt Oligopeptide mit reduziertem C-Terminus, insbesondere solche aus 2 bis 50 Monomeren, sind zu diesem Zweck beschrieben. Zu den peptidischen reversiblen Proteaseinhibitoren gehören unter anderem Ovomucoid und Leupeptin. Auch spezifische, reversible Peptid-Inhibitoren sowie Fusionsproteine aus Proteasen und spezifischen Peptid-Inhibitoren werden hierfür eingesetzt.Polyols, in particular glycerol and 1,2-propylene glycol, benzamidine hydrochloride, borax, boric acids, boronic acids or their salts or esters are established as reversible protease inhibitors in the prior art. These include, in particular, derivatives with aromatic groups, for example ortho, meta or para-substituted phenylboronic acids, in particular 4-formylphenylboronic acid (4-FPBA) or the salts or esters of the abovementioned compounds. A particularly good protection results when boric acid derivatives are used together with polyols, since they can then form a complex stabilizing the enzyme. Also peptide aldehydes, that is oligopeptides with reduced C-terminus, especially those of 2 to 50 monomers, are described for this purpose. Among the peptidic reversible protease inhibitors include ovomucoid and leupeptin. Also, specific, reversible peptide inhibitors and fusion proteins from proteases and specific peptide inhibitors are used for this purpose.

Polyole wie Glycerin und 1,2-Propylenglycol haben sich jedoch aufgrund ihrer hohen notwendigen Einsatzkonzentrationen als unvorteilhaft erwiesen, weil die übrigen Wirkstoffe der betreffenden Mittel damit nur noch in entsprechend geringeren Anteilen enthalten sein können.However, polyols such as glycerol and 1,2-propylene glycol have proved to be unfavorable due to their high necessary use concentrations, because the other active ingredients of the respective agents can thus be contained only in proportionally smaller proportions.

Unter den bereits in vergleichsweise niedriger Konzentration wirksamen Serin-Protease-Inhibitoren nehmen Borsäurederivate eine herausragende Stellung ein. Beispielsweise offenbart die internationale Patentanmeldung WO 96/21716 A1 dass als Proteaseinhibitoren wirkende Borsäurederivate auch geeignet sind, Enzyme in Wasch- und Reinigungsmitteln zu stabilisieren. Eine Auswahl besonders leistungsfähiger Stabilisatoren sind offenbart in der internationalen Patentanmeldung WO 96/41859 A1 .Boric acid derivatives occupy an outstanding position among the serine protease inhibitors, which are effective at comparatively low concentrations. For example, the international patent application discloses WO 96/21716 A1 that boric acid derivatives acting as protease inhibitors are also suitable for stabilizing enzymes in detergents and cleaners. A selection of particularly powerful stabilizers are disclosed in the international patent application WO 96/41859 A1 ,

Unabhängig von ihrer stabilisierenden Wirkung weisen die Borsäurederivate jedoch einen entscheidenden Nachteil auf. Viele Borsäurederivate, wie beispielsweise Borat, bilden mit einigen anderen Wasch- bzw. Reinigungsmittelinhaltsstoffen unerwünschte Nebenprodukte, so dass diese in den betreffenden Mitteln nicht mehr für den erwünschten Reinigungszweck zur Verfügung stehen oder sogar als Verunreinigung auf dem Waschgut zurückbleiben.Regardless of their stabilizing effect, however, the boric acid derivatives have a decisive disadvantage. Many boric acid derivatives, such as borate, form with some other detergent or detergent ingredients unwanted by-products, so that they are no longer available in the relevant agents for the desired cleaning purpose or even remain as an impurity on the laundry.

Es stellte sich somit die Aufgabe, borfreie chemische Verbindungen zur Verfügung zu stellen, die als Enzyminhibitoren wirken und somit als Enzymstabilisatoren in Wasch- und Reinigungsmitteln geeignet sind. Mit dieser Aufgabe ist als weitere Aufgabe der vorliegenden Erfindung verbunden, borfreie chemische Verbindungen zur Verfügung zu stellen, die als Proteaseinhibitoren wirken und somit als Stabilisatoren für Proteasen und/oder auch für andere Enzyme in Wasch- und Reinigungsmitteln geeignet sind. Insbesondere sollte ein Wasch- oder Reinigungsmittel mit einer solchen borfreien chemischen Verbindung bereitgestellt werden.It was therefore the task of providing boron-free chemical compounds which act as enzyme inhibitors and are thus suitable as enzyme stabilizers in detergents and cleaners. Another object of the present invention is to provide boron-free chemical compounds which act as protease inhibitors and are thus suitable as stabilizers for proteases and / or for other enzymes in detergents and cleaners. In particular, a washing or cleaning agent should be provided with such a boron-free chemical compound.

Hierbei war der Einsatz in insgesamt flüssigen, gelförmigen oder pastösen Wasch- und Reinigungsmitteln von besonderem Interesse, und darunter insbesondere in solchen, die Wasser enthalten.Here, the use in total liquid, gel or pasty detergents and cleaning agents of particular interest, and including in particular those containing water.

Ein Gegenstand der Erfindung ist ein Wasch- oder Reinigungsmittel, enthaltend ein Enzym und eine Verbindung der allgemeinen Strukturformel

Figure imgb0001
in der X ein aliphatischer oder ein aromatischer Rest ist und Y ein aliphatischer oder ein aromatischer Rest ist, wobei der Rest X ausgewählt ist aus der Gruppe bestehend aus -CH2-CH2-CH3, Phenyl.An object of the invention is a washing or cleaning agent containing an enzyme and a compound of the general structural formula
Figure imgb0001
wherein X is an aliphatic or an aromatic radical and Y is an aliphatic or an aromatic radical, wherein the radical X is selected from the group consisting of -CH 2 -CH 2 -CH 3 , phenyl.

Überraschenderweise wurde festgestellt, dass solche Verbindungen die in den erfindungsgemäßen Wasch- und Reinigungsmitteln enthaltenen Enzyme, beispielsweise insbesondere Proteasen, überraschend effektiv stabilisieren, und dies im Vergleich mit Borat als Enzymstabilisator bereits bei einer niedrigeren oder gleich hoher Konzentration. Diese Verbindungen schaffen damit Freiraum für Formulierung von Wasch- und Reinigungsmitteln durch die Möglichkeit, Enzymstabilisatoren, die aus dem Stand der Technik bekannt sind wie beispielsweise 1,2-Propylenglykol oder Borverbindungen (zum Beispiel Borate und andere Borsäurederivate oder 4-FPBA), in geringerer Konzentration einsetzen zu können oder vollständig auf diese zu verzichten.It has surprisingly been found that such compounds surprisingly effectively stabilize the enzymes contained in the detergents and cleaning agents according to the invention, for example, in particular proteases, and this compared to borate as enzyme stabilizer already at a lower or the same high concentration. These compounds thus provide scope for formulation of laundry detergents and cleaners by the ability of enzyme stabilizers known in the art, such as 1,2-propylene glycol or boron compounds (for example, borates and other boric acid derivatives or 4-FPBA), in lesser To be able to use concentration or to completely dispense with it.

In einer bevorzugten Ausführungsform der Erfindung ist das Wasch- oder Reinigungsmittel dadurch gekennzeichnet, dass die Reste X und Y der Verbindung identisch sind, wobei der Rest X ausgewählt ist aus der Gruppe bestehend aus: -CH2CH2CH3, Phenyl, und der Rest Y ebenfalls ausgewählt ist aus der Gruppe bestehend aus: -CH2-CH2-CH3, Phenyl. Eine besonders bevorzugte Verbindung weist daher als Rest X und als Rest Y eine : -CH2-CH2-CH3- Gruppe auf. Eine weitere besonders bevorzugte Verbindung weist demnach als Rest X und als Rest Y eine Phenylgruppe auf. Jedoch stellen alle Wasch- und Reinigungsmittel mit Verbindungen der oben angegebenen allgemeinen Strukturformel weitere Ausführungsformen der vorliegenden Erfindung dar, sofern die Reste X und Y jeweils aliphatisch oder aromatisch sind und diese Verbindung eine Stabilisierung eines Enzyms in dem Wasch- oder Reinigungsmittel bewirkt. Ebenso ist es möglich, dass der Rest X aliphatisch und der Rest Y aromatisch ist oder der Rest X aromatisch ist und der Rest Y aliphatisch ist.In a preferred embodiment of the invention, the washing or cleaning agent is characterized in that the radicals X and Y of the compound are identical, wherein the radical X is selected from the group consisting of: -CH 2 CH 2 CH 3 , phenyl, and the Rest Y as well is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl. A particularly preferred compound therefore has as radical X and as radical Y a: -CH 2 -CH 2 -CH 3 - group. A further particularly preferred compound accordingly has as radical X and as radical Y a phenyl group. However, all detergents and cleaners containing compounds of the general structural formula given above constitute further embodiments of the present invention, provided that the radicals X and Y are each aliphatic or aromatic and this compound effects a stabilization of an enzyme in the washing or cleaning agent. It is also possible that the radical X is aliphatic and the radical Y is aromatic or the radical X is aromatic and the radical Y is aliphatic.

Unter einem Wasch- oder Reinigungsmittel sind erfindungsgemäß alle Mittel zu verstehen, die sich zum Waschen oder Reinigen von insbesondere Textilien und/oder festen Oberflächen eignen.Under a detergent or cleaning agent according to the invention are all means that are suitable for washing or cleaning of particular textiles and / or solid surfaces.

Unter einem Enzym ist im Sinne der vorliegenden Anmeldung ein Protein zu verstehen, das eine bestimmte biokatalytische Funktion ausübt. Unter Protease im Sinne der vorliegenden Anmeldung wird ein Enzym verstanden, welches die Hydrolyse von Peptidbindungen katalysiert und dadurch in der Lage ist, Peptide oder Proteine zu spalten.For the purposes of the present application, an enzyme is to be understood as meaning a protein which has a specific biocatalytic function. For the purposes of the present application, protease is understood as meaning an enzyme which catalyzes the hydrolysis of peptide bonds and is thereby able to cleave peptides or proteins.

Die vorliegende Erfindung umfaßt die genannten Verbindungen in allen protonierten und/oder deprotonierten Formen. Gegebenenfalls sind entgegengesetzt geladene Kationen (H+, Na+, K+ oder ähnliche) bzw. Anionen (Cl-, Br-, Formiat, Acetat etc.) anwesend. In all diesen Formen kann die vorliegende Erfindung verwirklicht werden. Entscheidend ist jeweils die Wechselwirkung zwischen der erfindungsrelevanten Verbindung, die das Enzym stabilisiert und dem erfindungsgemäß zu stabilisierenden Enzym.The present invention encompasses the compounds mentioned in all protonated and / or deprotonated forms. Optionally, oppositely charged cations (H + , Na + , K + or the like) or anions (Cl - , Br - , formate, acetate, etc.) are present. In all these forms, the present invention can be realized. Decisive in each case is the interaction between the invention-relevant compound which stabilizes the enzyme and the enzyme to be stabilized according to the invention.

Ohne an diese Theorie gebunden sein zu müssen wird erfindungsgemäß davon ausgegangen, daß die erfindungsrelevanten Verbindungen, d.h. der stabilisierenden Verbindungen, mit dem zu stabilisierenden Enzym einen Komplex bilden. Voraussichtlich erfolgt eine nicht-kovalente Bindung der stabilisierenden Verbindung in oder an der Substratbindungstasche des Enzyms. Auf diese Weise wird das aktive Zentrum des Enzyms durch eine nicht durch dieses Enzym hydrolysierbare Verbindung blockiert und steht daher nicht mehr für die Katalyse anderer zugegener Substrate zur Verfügung. Die stabilisierende Wirkung der Verbindung erfolgt daher durch eine Inhibition des Enzyms. Hierbei handelt es sich um eine reversible Bindung, d.h. um ein Gleichgewicht zwischen Assoziation und Dissoziation. Der Gleichgewichtskoeffizient dieser Reaktion wird als Inhibitionskonstante oder Ki bezeichnet. Auf Grund der reversiblen Bindung der stabilisierenden Verbindung an das Enzym ist das Enzym in dem Wasch- bzw. Reinigungsmittel inhibiert und damit stabilisiert, wohingegen die Komplexe durch die veränderten Bedingungen beim Einsatz des Wasch- und Reinigungsmittels verstärkt dissoziieren, beispielsweise durch die Verdünnung des Wasch- bzw. Reinigungsmittels in der Wasch- bzw. Reinigungslösung, durch das Vorhandensein weiterer und/oder höheraffiner Enzymsubstrate oder durch die Veränderung des pH-Wertes in der Wasch- bzw. Reinigungslösung. Die Begriffe "stabilisierend" und "inhibierend" bzw. "hemmend" sowie "Stabilisator" und "Inhibitor" bzw. "Hemmstoff" sind in der vorliegenden Patentanmeldung daher als gleichbedeutend zu betrachten.Without having to be bound by this theory, it is assumed according to the invention that the compounds relevant for the invention, ie the stabilizing compounds, form a complex with the enzyme to be stabilized. It is anticipated that non-covalent binding of the stabilizing compound will occur in or at the substrate binding pocket of the enzyme. In this way, the active site of the enzyme is blocked by a compound which is not hydrolyzable by this enzyme and is therefore no longer available for the catalysis of other substrates present. The stabilizing effect of the compound is therefore due to an inhibition of the enzyme. This is a reversible bond, ie a balance between association and dissociation. The equilibrium coefficient of this reaction is called the inhibition constant or K i . Due to the reversible binding of the stabilizing compound to the enzyme, the enzyme is inhibited and thus stabilized in the washing or cleaning agent, whereas the complexes are increasingly dissociated by the changed conditions when using the detergent and cleaning agent, for example by dilution of the detergent Washing or cleaning agent in the washing or cleaning solution, by the presence of further and / or higher affinity enzyme substrates or by changing the pH in the washing or cleaning solution. The terms "stabilizing" and "inhibiting" or "inhibiting" as well as "stabilizer" and "inhibitor" or "inhibitor" are therefore to be regarded as synonymous in the present patent application.

Da der Gleichgewichtskoeffizient bzw. die Inhibitionskonstante Ki wie beschrieben für die Funktionalität der Verbindung als Enzymstabilisator von wesentlicher Bedeutung ist, stellt einen weiteren Gegenstand der Erfindung ein Wasch- oder Reinigungsmittel dar, welches dadurch gekennzeichnet ist, dass die Verbindung bezüglich des Enzyms eine Inhibitionskonstante (Ki) von 0,01 bis 10 mM aufweist. In einer weiter bevorzugen Ausführungsform der Erfindung ist das Wasch- oder Reinigungsmittel dadurch gekennzeichnet, dass die stabilisierende Verbindung bezüglich des Enzyms eine Inhibitionskonstante (Ki) von 0,03 bis 5 mM aufweist.Since the equilibrium coefficient or the inhibition constant K i is of essential importance for the functionality of the compound as an enzyme stabilizer, a further subject of the invention is a washing or cleaning agent which is characterized in that the compound has an inhibition constant with respect to the enzyme. K i ) of 0.01 to 10 mM. In a further preferred embodiment of the invention, the washing or cleaning agent is characterized in that the stabilizing compound has an inhibition constant (K i ) of 0.03 to 5 mM with respect to the enzyme.

Die Inhibitionskonstante Ki kann auf folgende Weise ermittelt werden:

  • Für die Charakterisierung eines reversiblen Inhibitors der enzymatischen Aktivität ist die Inhibitionskonstante Ki eine charakteristische und entscheidende Größe. Ki beschreibt das Gleichgewicht zwischen Enzym, Inhibitor und Enzym-Inhibitor Komplex für eine reversible Bindung. Der Enzym-Inhibitor Komplex ist dabei katalytisch nicht aktiv und inhibiert die Reaktion durch Herabsetzung der Konzentration von freiem Enzym, das noch zur Bindung von Substrat zur Verfügung steht. Der Ki ist dementsprechend definiert als: K i = I x E / EI
    Figure imgb0002
The inhibition constant K i can be determined in the following way:
  • For the characterization of a reversible inhibitor of enzymatic activity, the inhibition constant K i is a characteristic and decisive factor. K i describes the equilibrium between enzyme, inhibitor and enzyme-inhibitor complex for reversible binding. The enzyme-inhibitor complex is catalytically inactive and inhibits the reaction by reducing the concentration of free enzyme that is still available for binding of substrate. The K i is accordingly defined as: K i = I x e / EGG
    Figure imgb0002

Darin bedeuten [E], [I] und [EI] die jeweiligen molaren Gleichgewichtskonzentrationen von Enzym (E), Inhibitor (I) und dem Enzym-Inhibitor-Komplex (EI). Dieser Definition entsprechend ist eine Substanz mit einem kleinen Ki unter den jeweiligen Testbedingungen ein guter Inhibitor.Therein, [E], [I] and [EI] represent the respective molar equilibrium concentrations of enzyme (E), inhibitor (I) and the enzyme-inhibitor complex (EI). According to this definition, a substance with a small K i is a good inhibitor under the respective test conditions.

Die Bestimmung des Ki erfolgt auf der Grundlage des Aktivitätstests der Protease in Anwesenheit des entsprechenden Inhibitors. Über die im Stand der Technik etablierte und dem Fachmann bekannte Michaelis-Menten-Kinetik ( Leonor Michaelis, Maud Menten (1913). Die Kinetik der Invertinwirkung, Biochem. Z. 49:333-369 ) werden die enzymatischen Parameter Km, und kcat in Anwesenheit verschiedener Konzentrationen des Inhibitors bestimmt. Für eine Michaelis-Menten-Kinetik gilt vereinfacht: E + S k 1 k 1 ES k 2 E + P

Figure imgb0003
The determination of K i is carried out on the basis of the activity test of the protease in the presence of the corresponding inhibitor. About the Michaelis-Menten kinetics established in the prior art and known to those skilled in the art ( Leonor Michaelis, Maud Menten (1913). The kinetics of invertin action, Biochem. Z. 49: 333-369 ), the enzymatic parameters K m , and k cat are determined in the presence of various concentrations of the inhibitor. For a Michaelis-Menten kinetics is simplified: e + S k 1 k 1 IT k 2 e + P
Figure imgb0003

Hierin bedeuten:

  • E: Enzym
  • S: Substrat
  • ES: Enzym-Substrat-Komplex
  • P: Produkt
  • k1,k-1,k2: Geschwindigkeitskonstanten
Herein mean:
  • E: enzyme
  • S: substrate
  • ES: enzyme-substrate complex
  • P: product
  • k 1 , k -1 , k 2 : rate constants

Hierin ist k2 ein Maß der maximalen Reaktionsgeschwindigkeit bei Substratsättigung (Vmax), auch Wechselzahl, molekulare Aktivität, "turnover number" oder kcat genannt (kcat = Vmax/ [Eo], wobei [Eo] die Ausgangskonzentration des Enzyms ist). Die Michaeliskonstante (d.h. die Substratkonzentration, die bei der Halbsättigung vorliegt, bei der die Umsatzgeschwindigkeit also v = Vmax/2 beträgt), ergibt sich zuHere, k 2 is a measure of the maximum reaction rate at substrate saturation (Vmax), also called turnover number, molecular activity, turnover number or kcat (kcat = Vmax / [Eo], where [Eo] is the initial concentration of the enzyme). The Michaelis constant (ie the substrate concentration present at half-saturation, where the rate of turnover is thus v = Vmax / 2), is too high

Km = k-1 / k1 (Michaelis-Menten-Fall, gegeben wenn k2<< k1) oder bzw. allgemeiner zu Km = k-1 + k2 / k1 (Briggs-Haldane-Situation, gegeben für den Fall, dass k 2 gegenüber k 1 nicht vernachlässigt werden kann).K m = k -1 / k 1 (Michaelis-Menten case, given k2 << k1) or more generally K m = k -1 + k 2 / k 1 (Briggs-Haldane situation, given for the Case that k 2 can not be neglected compared to k 1).

Die Sättigungsfunktion eines "Michaelis-Menten Enzyms" ergibt sich unter Verwendung der Parameter Km und Vmax wie folgt: v = v max S K m + S

Figure imgb0004
The saturation function of a "Michaelis-Menten enzyme" is calculated using the parameters Km and Vmax as follows: v = v Max S K m + S
Figure imgb0004

Hierin bedeutet:

  • v: Bildungsgeschwindigkeit von P (v = "Geschwindigkeit") [mol I-1 s-1]
  • vmax: maximale Geschwindigkeit [mol I-1 s-1]
  • Km: Michaelis-Menten-Konstante [mol I-1]
  • [S]: Substratkonzentration [mol I-1]
Hereby means:
  • v: formation rate of P (v = "velocity") [mol I-1 s-1]
  • vmax: maximum velocity [mol I-1 s-1]
  • Km: Michaelis-Menten constant [mol I-1]
  • [S]: substrate concentration [mol I-1]

Durch die Bestimmung der Anfangskatalyse-Rate (vAnf.) - für Proteasen der Anfangshydrolyse-Rate - bei verschiedenen Substratkonzentrationen [S] und Einpassung der experimentellen Daten in nachstehende Gleichung 1 wird die Inhibitionskonstante Ki erhalten. v Anf . = k cat × S x E 0 / K m x 1 + I / K i + S ]

Figure imgb0005
Determination of the initial catalysis rate (v Anf. ) - for proteases of the initial hydrolysis rate - at various substrate concentrations [S] and fitting of the experimental data into Equation 1 below gives the inhibition constant K i . v anf , = k cat × S x e 0 / K m x 1 + I / K i + S ]
Figure imgb0005

Hierin steht [I] wiederum für die Inhibitor-Konzentration.Here again [I] stands for the inhibitor concentration.

Alternativ kann Ki unter Verwendung der Cheng-Prusoff-Gleichung ( Gleichung 2, Cheng Y., Prusoff W.H. (1973) Biochem.Pharmacol. 22, 3099-3108 ) über den IC50-Wert bestimmt werden. Die Bestimmung des IC50-Werts erfolgt über die Bestimmung der katalytischen Aktivität an einem Substrat in Anwesenheit verschiedener Konzentrationen des Inhibitors und der Anpassung der experimentellen Daten an eine sigmoidale Dosis-Wirkungs-Gleichung mit variabler Steigung (Pseudo-Hill-Steigungen). Es handelt sich dabei um die Inhibitor-Konzentration, die nötig ist, um eine 50%ige Inhibition zu erreichen.Alternatively, K i can be calculated using the Cheng-Prusoff equation ( Equation 2, Cheng Y., Prusoff WH (1973) Biochem. Pharmacol. 22, 3099-3108 ) are determined via the IC 50 value. The determination of the IC 50 via the determination of the catalytic activity to a substrate in the presence of various concentrations of the inhibitor and the fitting of the experimental data to a sigmoidal dose-response with variable slope equation (pseudo-Hill slopes). It is the inhibitor concentration needed to achieve 50% inhibition.

Ki ergibt sich damit aus folgender Gleichung 2: K i = IC 50 / 1 + S / K d

Figure imgb0006
K i results from the following equation 2: K i = IC 50 / 1 + S / K d
Figure imgb0006

Darin bedeuten [S] die Substratkonzentration im Test und Kd die Dissoziationskonstante für das Substrat, die bei der IC50-Konzentration des Inhibitors als identisch mit Km für das Substrat gesetzt werden kann.Therein, [S] is the substrate concentration in the assay and K d is the dissociation constant for the substrate, which at the IC 50 concentration of the inhibitor can be considered to be identical to K m for the substrate.

Die auf diese Weise bestimmbaren Ki-Werte kennzeichnen die Verbindung in Bezug auf das eingesetzte Enzym. In Beispiel 1 wurde die Restaktivität einer Protease, nämlich die Bacillus lentus-Alkalische Protease F49 (gemäß WO 95/23221 A1 ) in Gegenwart eines Inhibitors bestimmt. Da es sich dabei um eine typische Subtilisin-Protease handelt, sind die mit diesem Enzym erhaltenen Werte auch für andere Serin-Proteasen, insbesondere andere Subtilisin-Proteasen typisch. Der exakte Wert für ein interessierendes Enzym muss im Zweifel anhand des jeweils konkreten Enzyms ermittelt werden.The K i values that can be determined in this way characterize the compound with respect to the enzyme used. In Example 1, the residual activity of a protease, namely the Bacillus lentus alkaline protease F49 (according to WO 95/23221 A1 ) in the presence of an inhibitor. Since this is a typical subtilisin protease, the values obtained with this enzyme are also typical of other serine proteases, in particular other subtilisin proteases. The exact value for an enzyme of interest must be determined in case of doubt based on the specific enzyme.

Wie vorstehend bereits erläutert ist ein Vorteil der erfindungsgemäßen Verbindungen, die in Wasch- und Reinigungsmitteln die Stabilisierung mindestens eines Enzyms bewirken, gegenüber dem Stand der Technik, dass sie günstige Inhibitionskonstanten bezüglich der in Wasch- und Reinigungsmitteln einzusetzenden Enzyme aufweisen. Dies gilt insbesondere für Proteasen, aber auch für andere Enzyme. Eine weitgehend reversible Bindung der Inhibitoren ist somit gewährleistet, d.h. sie gehen nicht zu feste und nicht zu lose vorübergehende Wechselwirkungen mit dem Enzym ein. Vorteilhafterweise liegt damit während der Lagerung der Wasch- und Reinigungsmittel der Großteil der Enzyme in Form eines Enzym-Inhibitor-Komplexes vor. Die Enzyme, insbesondere Proteasen, und ggf. weitere vorhandene Proteine werden auf diese Weise geschützt, beispielsweise gegenüber katalytischen, insbesondere hydrolytischen Aktivitäten dieser Enzyme selbst. Im Falle von Proteasen sind diese daher vor einer Proteolyse durch diese Enzyme geschützt, d.h. sie sind gegen Proteolyse stabilisiert. Im Augenblick der Verdünnung des erfindungsgemäßen Wasch- oder Reinigungsmittels mit Wasser zur Herstellung einer wäßrigen Wasch- bzw. Reinigungslösung während des Reinigungsvorgangs wird das Bindungsgleichgewicht in Richtung Dissoziation verschoben, so dass sich der Komplex auflöst und der Großteil der erfindungsrelevanten Enzyme katalytisch aktiv wird. Es handelt sich bei den erfindungsrelevanten Verbindungen also gemäß der formulierten Aufgabe um funktionierende Enzym-Inhibitoren und somit um Enzym-Stabilisatoren für Wasch- und Reinigungsmittel.As already explained above, an advantage of the compounds according to the invention which effect the stabilization of at least one enzyme in detergents and cleaners is that they have favorable inhibition constants with respect to the enzymes to be used in detergents and cleaning agents compared with the prior art. This is especially true for proteases, but also for other enzymes. A largely reversible binding of the inhibitors is thus ensured, ie they do not enter into solid and not too loose transient interactions with the enzyme. Advantageously, the majority of the enzymes are thus present in the form of an enzyme-inhibitor complex during storage of the detergents and cleaners. The enzymes, in particular proteases, and optionally other proteins present are protected in this way, for example against catalytic, in particular hydrolytic activities of these enzymes themselves. In the case of proteases, these are therefore protected from proteolysis by these enzymes, ie they are stabilized against proteolysis , At the moment of dilution of the washing or cleaning agent according to the invention with water to prepare an aqueous washing or cleaning solution during the cleaning process, the binding equilibrium shifted in the direction of dissociation, so that the complex dissolves and the majority of the invention relevant enzymes is catalytically active. Thus, the compounds relevant to the invention are functional enzyme inhibitors according to the task formulated and thus enzyme stabilizers for detergents and cleaners.

Ferner weisen erfindungsgemäße Verbindungen im Vergleich mit etablierten Enzymstabilisatoren aus dem Stand der Technik, beispielsweise gegenüber Polyolen, einen geringen Volumenbedarf auf.Furthermore, compounds according to the invention have a low volume requirement in comparison with established prior art enzyme stabilizers, for example with respect to polyols.

Ein weiterer Vorteil der erfindungsrelevanten Verbindungen gegenüber dem Stand der Technik besteht darin, daß sie als Elemente lediglich Kohlenstoff (C), Wasserstoff (H), Phosphor (P) und Sauerstoff (O) aufweisen und insbesondere frei von Bor sind. Sie bilden somit nicht die unerwünschten, auf Bor zurückzuführenden Nebenprodukte mit anderen Wasch- oder Reinigungsmittelinhaltsstoffen.Another advantage of the invention relevant compounds over the prior art is that they have as elements only carbon (C), hydrogen (H), phosphorus (P) and oxygen (O) and in particular are free of boron. Thus, they do not form the undesirable boron-derived by-products with other detergent or cleaning ingredients.

Ferner verfügen sie über eine gute Wasserlöslichkeit, so dass sie in entsprechende Wasch- und Reinigungsmittel einfach eingearbeitet werden können. Weiterhin wird dadruch ein Ausfällen während der Lagerung vermindert bzw. ganz vermieden.Furthermore, they have a good solubility in water, so that they can be easily incorporated into appropriate detergents and cleaners. Furthermore dadruch a precipitation during storage is reduced or completely avoided.

Grundsätzlich wirken die genannten Verbindungen vermutlich deshalb als reversible Inhibitoren, weil sie dem Substrat der Enzyme, betreffend Proteasen insbesondere hinsichtlich der zu hydrolysierenden Säureamidbindung, strukturell gleichen. Umgekehrt lassen sich also die Enzyme, bevorzugt proteolytische Enzyme, durch die erfindungsrelevanten Verbindungen inhibieren. Dies gilt insbesondere für Serin-Proteasen, wie anhand der Beispiele zur vorliegenden Anmeldung mit der positiven Wirkung der beschriebenen Verbindungen anhand von Subtilisinen gezeigt ist.In principle, the compounds mentioned are presumed to act as reversible inhibitors because they structurally resemble the substrate of the enzymes, concerning proteases, in particular with regard to the acid amide bond to be hydrolyzed. Conversely, the enzymes, preferably proteolytic enzymes, can thus be inhibited by the compounds relevant to the invention. This applies in particular to serine proteases, as shown by the examples of the present application with the positive effect of the described compounds on the basis of subtilisins.

In erfindungsgemäßen Wasch- oder Reinigungsmitteln, die in einer bevorzugten Ausführung in überwiegend fester Form vorliegen und in einer zweiten Ausführung in überwiegend flüssiger, pastöser oder Gelform vorliegen, ist das Enzym insbesondere in einem Gehalt von 2 µg bis 20 mg pro g des Mittels, vorzugsweise von 5 µg bis 17,5 mg pro g des Mittels, besonders bevorzugt von 20 µg bis 15 mg pro g des Mittels, ganz besonders bevorzugt von 50 µg bis 10 µg des Mittels enthalten.In detergents or cleaners according to the invention, which are present in a preferred embodiment in predominantly solid form and in a second embodiment in predominantly liquid, pasty or gel form, the enzyme is in particular in a content of 2 .mu.g to 20 mg per g of the composition, preferably from 5 μg to 17.5 mg per g of the agent, more preferably from 20 μg to 15 mg per g of the agent, most preferably from 50 μg to 10 μg of the agent.

Die Verbindung, d.h. der Stabilisator, ist in erfindungsgemäßen Mitteln insbesondere in einem Gehalt bis zu 50 mg pro g des Mittels, vorzugsweise bis zu 10 mg besonders bevorzugt bis zu 7 mg ganz besonders bevorzugt bis zu 5 mg pro g des Mittels enthalten. Weiterhin ist bevorzugt, dass die in dem Mittel enthaltene Menge der Verbindung, d.h. der das Enzym stabilisierenden Verbindung, bezogen auf das stabilisierte Enzym von 0,01 bis 100 x der Inhibitionskonstante Ki, vorzugsweise 0,1 bis 10 x Ki, besonders bevorzugt 1 bis 5 x Ki, beträgt.The compound, ie the stabilizer, is contained in agents according to the invention in particular in a content of up to 50 mg per g of the agent, preferably up to 10 mg, more preferably up to 7 mg, very particularly preferably up to 5 mg per g of the agent. Furthermore, it is preferred that the amount of the compound contained in the agent, ie the stabilizing the enzyme Compound, based on the stabilized enzyme of 0.01 to 100 x the inhibition constant K i , preferably 0.1 to 10 x K i , more preferably 1 to 5 x K i .

Vorzugsweise beträgt das molare Verhältnis der stabilisierenden Verbindung zum Enzym 1:1 bis 1.000:1, insbesondere von 1:1 bis 500:1, besonders bevorzugt von 1:1 bis 100:1, ganz besonders bevorzugt von 1:1 1 bis 20:1.The molar ratio of the stabilizing compound to the enzyme is preferably 1: 1 to 1000: 1, in particular from 1: 1 to 500: 1, particularly preferably from 1: 1 to 100: 1, very particularly preferably from 1: 1 1 to 20: 1.

Einen weiteren Gegenstand der Erfindung bilden Wasch- oder Reinigungsmittel, die dadurch gekennzeichnet, dass das Enzym ausgewählt ist aus der Gruppe bestehend aus: Protease, Amylase, Cellulase, Hemicellulase, Mannanase, Tannase, Xylanase, Xanthanase, β-Glucosidase, Carrageenase, Oxidase, Oxidoreduktase, Lipase, Esterase oder Mischungen hiervon. In einer besonders bevorzugten Ausführungsform der Erfindung ist das Wasch- oder Reinigungsmittel dadurch gekennzeichnet, dass das Enzym eine Protease, bevorzugt eine Serinprotease, weiter bevorzugt eine Subtilase und besonders bevorzugt ein Subtilisin ist. Denn insbesondere für Wasch- und Reinigungsmittel oder allgemein Enzym enthaltende Kompositionen wie Enzymhochkonzentrate, die mindestens ein proteolytisches Enzym (Protease) beinhalten, ist die Lagerstabilität der Enzyme ein generelles Problem. Proteolytische Enzyme führen auf Grund ihrer enzymatischen Aktivität zur Hydrolyse von Proteinen wie zum Beispiel Enzymen und Peptiden, die in der Zusammensetzung enthalten sind, seien es andere Proteine bzw. Enzyme oder aber auch die Proteasen selbst. Eine Hydrolyse der Protease durch deren eigene proteolytische Aktivität wird als Autoproteolyse bezeichnet. Das Maß der Lagerstabilität von allen in einer Protein-/Enzymkomposition enthaltenen Proteinen/Enzymen ist damit insbesondere abhängig von der proteolytischen Aktivität einer Protease innerhalb dieser Komposition. Um die Lagerstabilität aller Enzyme einer solchen Komposition zu erhöhen ist es daher notwendig, gerade die proteolytische Aktivität der Protease während der Lagerzeit zu inhibieren. Dies geschieht im günstigsten Fall durch die Zugabe einer erfindungsgemäßen Verbindung, die für die in der Zusammensetzung enthaltene Protease einen spezifischen und reversiblen Inhibitor mit einer hohen Affinität zur Protease darstellt.Another object of the invention are detergents or cleaners characterized in that the enzyme is selected from the group consisting of: protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, β-glucosidase, carrageenase, oxidase, Oxidoreductase, lipase, esterase or mixtures thereof. In a particularly preferred embodiment of the invention, the washing or cleaning agent is characterized in that the enzyme is a protease, preferably a serine protease, more preferably a subtilase and most preferably a subtilisin. Because in particular for detergents and cleaners or generally enzyme-containing compositions such as enzyme concentrates containing at least one proteolytic enzyme (protease), the storage stability of the enzymes is a general problem. Due to their enzymatic activity, proteolytic enzymes lead to the hydrolysis of proteins, such as enzymes and peptides, which are contained in the composition, be it other proteins or enzymes or also the proteases themselves. Hydrolysis of the protease by its own proteolytic activity becomes referred to as autoproteolysis. The degree of storage stability of all proteins / enzymes contained in a protein / enzyme composition is thus dependent, in particular, on the proteolytic activity of a protease within this composition. In order to increase the storage stability of all enzymes of such a composition, it is therefore necessary to precisely inhibit the proteolytic activity of the protease during storage. This is best done by the addition of a compound of the invention which is a specific and reversible inhibitor with a high affinity for the protease for the protease contained in the composition.

Beispiele für solche Proteasen sind die Subtilisine BPN' und Carlsberg, die Protease PB92, die Subtilisine 147 und 309, die Alkalische Protease aus Bacillus lentus, Subtilisin DY und die den Subtilasen, nicht mehr jedoch den Subtilisinen im engeren Sinne zuzuordnenden Enzyme Thermitase, Proteinase K und die Proteasen TW3 und TW7. Subtilisin Carlsberg ist in weiterentwickelter Form unter dem Handelsnamen Alcalase® von der Firma Novozymes A/S, Bagsværd, Dänemark, erhältlich. Die Subtilisine 147 und 309 werden unter den Handelsnamen Esperase®, beziehungsweise Savinase® von der Firma Novozymes vertrieben. Von der Protease aus Bacillus lentus DSM 5483 leiten sich die unter der Bezeichnung BLAP® geführten Protease-Varianten ab.Examples of such proteases are the subtilisins BPN 'and Carlsberg, the protease PB92, the subtilisins 147 and 309, the alkaline protease from Bacillus lentus, subtilisin DY and the enzymes thermitase, proteinase K which can no longer be assigned to the subtilisins in the narrower sense and the proteases TW3 and TW7. Subtilisin Carlsberg is available in a further developed form under the trade name Alcalase® from Novozymes A / S, Bagsværd, Denmark. The subtilisins 147 and 309 are sold under the trade names Esperase®, and Savinase® by the company Novozymes. From the protease from Bacillus lentus DSM 5483 derived under the name BLAP® protease variants derived.

Weitere Proteasen sind beispielsweise die unter den Handelsnamen Durazym®, Relase®, Everlase®, Nafizym, Natalase®, Kannase® und Ovozymes® von der Firma Novozymes, die unter den Handelsnamen, Purafect®, Purafect® OxP und Properase® von der Firma Genencor, das unter dem Handelsnamen Protosol® von der Firma Advanced Biochemicals Ltd., Thane, Indien, das unter dem Handelsnamen Wuxi® von der Firma Wuxi Snyder Bioproducts Ltd., China, die unter den Handelsnamen Proleather® und Protease P® von der Firma Amano Pharmaceuticals Ltd., Nagoya, Japan, und das unter der Bezeichnung Proteinase K-16 von der Firma Kao Corp., Tokyo, Japan, erhältlichen Enzyme.Other proteases are, for example, under the trade names Durazym ®, relase ®, Everlase® ®, Nafizym, Natalase ®, Kannase® ® and Ovozymes ® from Novozymes, under the trade names Purafect ®, Purafect ® OxP and Properase.RTM ® from Genencor , under the trade name Protosol® ® from Advanced Biochemicals Ltd., Thane, India, under the trade name Wuxi ® from Wuxi Snyder Bioproducts Ltd., China, under the trade names Proleather® ® and protease P ® from Amano Pharmaceuticals Ltd., Nagoya, Japan, and the enzyme available under the name Proteinase K-16 from Kao Corp., Tokyo, Japan.

Überraschenderweise wurde festgestellt, dass solche Proteasen besonders gut durch die erläuterten Verbindungen stabilisiert bzw. reversibel inhibiert werden. Zudem werden auch bestimmte Varianten von Proteasen, d.h. auch Varianten der genannten Proteasen, durch diese Verbindungen besonders vorteilhaft stabilisiert. Solche Protease-Varianten sind Teil der nachfolgend beschriebenen Erfindungsgegenstände.Surprisingly, it has been found that such proteases are particularly well stabilized or reversibly inhibited by the compounds described. In addition, certain variants of proteases, i. also variants of said proteases, stabilized by these compounds particularly advantageous. Such protease variants are part of the invention described below.

Eine erfindungsgemäß stabilisierte beziehungsweise reversibel inhibierte Protease kann ein Wildtypenzym oder eine Protease-Variante sein. Unter Wildtypenzym ist zu verstehen, dass das Enzym in einem natürlich vorkommenden Organismus bzw. in einem natürlichen Habitat vorhanden ist aus diesem isoliert werden kann. Enzyme sind jedoch veränderbar und werden zum Teil gezielt verändert, insbesondere um ihre Eigenschaften den vorgesehenen Einsatzzwecken anzupassen oder um ihre katalytische Aktivität zu beeinflussen. Diese Veränderungen erfolgen durch oftmals durch Änderung der Aminosäuresequenz des Enzyms. Solche Veränderungen können dabei gezielt und somit ortsgerichtet oder zufällig, beispielsweise durch Zufallsmutageneseverfahren, erfolgen. Unter einer Enzym-Variante werden Enzyme verstanden, die aus einem Ausgangsenzym, beispielsweise einem Wildtyp-Enzym, durch Veränderung der Aminosäuresequenz erzeugt wurden. Die Veränderung der Aminosäuresequenz erfolgt vorzugsweise durch Mutationen, wobei Aminosäure-Substitutionen, Deletionen, Insertionen oder Kombinationen hiervon vorgenommen sein können. Das Einbringen solcher Mutationen in Proteine ist Stand der Technik und dem Fachmann auf dem Gebiet der Enzymtechnologie hinlänglich bekannt. Grundsätzlich können alle Enzyme derartig verändert sein. Erfindungsgemäß bevorzugt sind Protease-Varianten. Diese wurden aus einer Ausgangsprotease, beispielsweise einer Wildtyp-Protease, durch Veränderung der Aminosäuresequenz erzeugt, wobei bevorzugt Aminosäure-Substitutionen, Deletionen, Insertionen oder Kombinationen hiervon vorgenommen wurden. Die Ausgangsprotease muss jedoch nicht zwingend eine natürlich vorkommende Wildtyp-Protease sein, auch eine aus dem Stand der Technik bekannte Protease, an der bereits Veränderungen vorgenommen wurden, kann weiterentwickelt werden und daher erneut als Ausgangsprotease zur Erzeugung weiter Protease-Varianten dienen.A protease stabilized or reversibly inhibited according to the invention can be a wild-type enzyme or a protease variant. Under wild-type enzyme is to be understood that the enzyme is present in a naturally occurring organism or in a natural habitat can be isolated from this. However, enzymes are modifiable and sometimes selectively modified, in particular in order to adapt their properties to the intended uses or to influence their catalytic activity. These changes often occur by altering the amino acid sequence of the enzyme. Such changes can be targeted and thus local or random, for example, by random mutagenesis done. An enzyme variant is understood as meaning enzymes which have been generated from an initial enzyme, for example a wild-type enzyme, by altering the amino acid sequence. The alteration of the amino acid sequence is preferably carried out by mutations, wherein amino acid substitutions, deletions, insertions or combinations thereof may be made. The incorporation of such mutations into proteins is well known in the art and to those skilled in the art of enzyme technology. In principle, all enzymes can be changed in this way. Protease variants are preferred according to the invention. These were generated from an initial protease, for example a wild-type protease, by altering the amino acid sequence, preferably amino acid substitutions, deletions, insertions or combinations thereof. However, the starting protease does not necessarily have to be a naturally occurring wild-type protease; a protease known from the prior art in which changes have already been made can also be further developed and therefore again serve as an initial protease for generating further protease variants.

Somit können beispielsweise alle der vorstehend beschriebenen Proteasen unverändert in erfindungsgemäßen Mitteln eingesetzt sein und durch die beschriebenen Verbindungen stabilisert sein. Sie können aber auch das Ausgangsenzym für eine Variante darstellen, welche dann in einem erfindungsgemäßen Mittel enthalten und durch die beschriebenen Verbindungen stabilisiert ist.Thus, for example, all of the proteases described above may be used unchanged in agents according to the invention and be stabilized by the compounds described. However, they can also be the starting enzyme for a variant which is then contained in an agent according to the invention and stabilized by the compounds described.

Unter allen beschriebenen Proteasen bzw. Varianten weiter bevorzugt ist das Wildtypenzym bzw. das Ausgangsenzym der Variante:

  • Die Alkalische Protease aus Bacillus amyloliquefaciens (BPN'),
  • Die Alkalische Protease aus Bacillus licheniformis (Subtilisin Carlsberg),
  • Die Alkalische Protease PB92,
  • Subtilisin 147 und/oder Subtilisin 309 (Savinase)
  • Die Alkalische Protease aus Bacillus lentus, vorzugsweise aus Bacillus lentus DSM 5483,
  • Die Alkalische Protease aus Bacillus alcalophilus (DSM 11233),
  • die Alkalische Protease aus Bacillus gibsonii (DSM 14391) oder eine hierzu mindestens zu 70% identische Alkalische Protease,
  • die Alkalische Protease aus Bacillus sp. (DSM 14390) oder eine hierzu mindestens zu 98,5% identische Alkalische Protease,
  • die Alkalische Protease aus Bacillus sp. (DSM 14392) oder eine hierzu mindestens zu 98,1 % identische Alkalische Protease,
  • die Alkalische Protease aus Bacillus gibsonii (DSM 14393) oder eine hierzu mindestens zu 70% identische Alkalische Protease.
Among all proteases or variants described further preferred is the wild-type enzyme or the starting enzyme of the variant:
  • The alkaline protease from Bacillus amyloliquefaciens (BPN '),
  • The alkaline protease from Bacillus licheniformis (subtilisin Carlsberg),
  • Alkaline Protease PB92,
  • Subtilisin 147 and / or subtilisin 309 (Savinase)
  • The alkaline protease from Bacillus lentus, preferably from Bacillus lentus DSM 5483,
  • The alkaline protease from Bacillus alcalophilus (DSM 11233),
  • the alkaline protease from Bacillus gibsonii (DSM 14391) or an at least 70% identical alkaline protease,
  • the alkaline protease from Bacillus sp. (DSM 14390) or at least 98.5% identical alkaline protease,
  • the alkaline protease from Bacillus sp. (DSM 14392) or an at least 98.1% identical alkaline protease,
  • the alkaline protease from Bacillus gibsonii (DSM 14393) or an at least 70% identical alkaline protease.

In einer weiteren Ausführungsform der Erfindung ist das Wasch- oder Reinigungsmittel daher dadurch gekennzeichnet, dass die Protease aus einer Ausgangsprotease durch mindestens eine Veränderung einer Aminosäure erhalten wurde, wobei die Veränderung eine Substitution, Insertion oder Deletion einer Aminosäure ist, und sie zu der Ausgangsprotease auf Aminosäureebene zu mindestens 90%, vorzugsweise mindestens 92,5%, besonders bevorzugt mindestens 95% und ganz besonders bevorzugt mindestens 97,5% identisch ist.In a further embodiment of the invention, the washing or cleaning agent is therefore characterized in that the protease was obtained from an initial protease by at least one change of an amino acid, the change being a substitution, insertion or deletion of an amino acid, and adding it to the parent protease Amino acid level is at least 90%, preferably at least 92.5%, more preferably at least 95% and most preferably at least 97.5% identical.

Verfahren zur Durchführung und Erstellung von Sequenzvergleichen, sogenannte Alignments, sind dem Fachmann auf dem Gebiet der Enzymtechnologie bekannt. Durch solche Sequenzvergleiche werden für zu vergleichende Sequenzen beispielsweise die Identitäts- oder Homologiewerte ermittelt. Solch ein Vergleich geschieht dadurch, dass ähnliche Abfolgen in den Nukleotid- oder Aminosäuresequenzen der betrachteten Proteine einander zugeordnet werden. Dies nennt man Homologisierung. Eine tabellarische Zuordnung der betreffenden Positionen wird als Alignment bezeichnet. Bei der Analyse von Nukleotidsequenzen sind wiederum beide komplementären Stränge und jeweils allen drei möglichen Leserastern zu berücksichtigen; ebenso die Degeneriertheit des genetischen Codes und die organismenspezifische Verwendung der Codons (Codon-Usage). Inzwischen werden Alignments über Computerprogramme erstellt, wie beispielsweise durch die Algorithmen FASTA oder BLAST; dieses Vorgehen wird beispielsweise von D. J. Lipman und W. R. Pearson (1985) in Science, Band 227, S. 1435-1441 beschrieben.Methods for carrying out and producing sequence comparisons, so-called alignments, are known to the person skilled in the art of enzyme technology. By means of such sequence comparisons, for example, the identity or homology values are determined for sequences to be compared. Such a comparison is accomplished by associating similar sequences in the nucleotide or amino acid sequences of the proteins of interest. This is called homologization. A tabular assignment of the respective positions is referred to as alignment. In the analysis of nucleotide sequences, in turn, both are complementary Strands and in each case all three possible reading frames to be considered; as well as the degeneracy of the genetic code and the organism-specific use of codons (codon usage). Meanwhile, alignments are created using computer programs, such as the algorithms FASTA or BLAST; This procedure is for example by DJ Lipman and WR Pearson (1985) in Science, Vol. 227, pp. 1435-1441 described.

Eine Zusammenstellung aller in den verglichenen Sequenzen übereinstimmenden Positionen wird als Konsensus-Sequenz bezeichnet.A summary of all matching positions in the compared sequences is called a consensus sequence.

Solch ein Vergleich erlaubt auch eine Aussage über die Ähnlichkeit oder Homologie der verglichenen Sequenzen zueinander. Diese wird in Prozent Identität, das heißt dem Anteil der identischen Nukleotide oder Aminosäurereste an denselben bzw. in einem Alignment einander entsprechenden Positionen wiedergegeben. Ein weiter gefasster Homologiebegriff bezieht die konservierten Aminosäure-Austausche in diesen Wert mit ein. Es ist dann von Prozent Ähnlichkeit die Rede. Solche Aussagen können über ganze Proteine oder Gene oder nur über einzelne Bereiche getroffen werden.Such a comparison also allows a statement about the similarity or homology of the compared sequences to each other. This is represented in percent identity, that is the proportion of identical nucleotides or amino acid residues at the same or in an alignment corresponding positions. A broader concept of homology includes the conserved amino acid substitutions in this value. It then speaks of percent similarity. Such statements can be made about whole proteins or genes or only over individual areas.

Homologe Bereiche von verschiedenen Proteinen sind durch Übereinstimmungen in der Aminosäuresequenz definiert. Diese können auch durch identische Funktion gekennzeichnet sein. Sie geht bis zu völligen Identitäten in kleinsten Bereichen, sogenannten Boxen, die nur wenige Aminosäuren umfassen und meist für die Gesamtaktivität essentielle Funktionen ausüben. Unter den Funktionen der homologen Bereiche sind kleinste Teilfunktionen der vom gesamten Protein ausgeübten Funktion zu verstehen, wie beispielsweise die Ausbildung einzelner Wasserstoffbrückenbindungen zur Komplexierung eines Substrats oder Übergangskomplexes.Homologous regions of different proteins are defined by matches in amino acid sequence. These can also be identified by identical function. It goes as far as complete identities in the smallest areas, so-called boxes, which contain only a few amino acids and usually perform essential functions for the overall activity. The functions of the homologous regions are to be understood as the smallest partial functions of the function carried out by the entire protein, such as, for example, the formation of individual hydrogen bonds for the complexation of a substrate or transition complex.

Insbesondere dienen solche Sequenzvergleiche bzw. Alignments auch zur Ermittlung von einander entsprechenden Positionen in unterschiedlichen Molekülen. So kann beispielsweise in einem Alignment von unterschiedlichen Enzymen festgestellt werden, welche Positionen in der jeweiligen Aminosäure- oder Nukleinsäuresequenz einander entsprechen, auch wenn die jeweiligen Sequenzen beispielsweise unterschiedliche Gesamtlängen oder unterschiedliche Domänen bzw. Teilsequenzen aufweisen oder wenn innerhalb einer Sequenz zusätzliche Aminosäuren bzw. Nukleotide vorhanden sind. Einer bestimmten Position in einer ersten Sequenz kann daher eine entsprechende Position in einer zweiten Sequenz konkret zugeordnet werden, wobei es durchaus möglich ist, dass sich die einander entsprechenden Positionen an unterschiedlichen Stellen im Molekül befinden. Ferner können an den entsprechenden Positionen unterschiedliche Aminosäurereste vorhanden sein. Daher wird für solche Sequenzvergleiche bzw. zur Bestimmung einer Position konkret angegeben, um welche Position es sich handelt und von welchem Enzym ausgegangen wird, d.h. welche Zählweise der Positionsbestimmung zu Grunde zu legen ist.In particular, such sequence comparisons or alignments also serve to determine mutually corresponding positions in different molecules. Thus, for example, in an alignment of different enzymes, it can be determined which positions in the respective amino acid or nucleic acid sequence correspond to one another, even if the respective sequences have, for example, different total lengths or different domains or partial sequences or if additional amino acids or nucleotides are present within a sequence are. A specific position in a first sequence can therefore be concretely assigned to a corresponding position in a second sequence, whereby it is quite possible for the positions corresponding to one another to be located at different locations in the molecule. Further, different amino acid residues may be present at the corresponding positions. Therefore, for such sequence comparisons or for the determination Specifically specified a position, which position it is and which enzyme is assumed, that is, which counting method of determining position is to be based.

Für die nachfolgenden Erfindungsgegenstände wird zur Positionsbestimmung die Aminosäuresequenz des reifen (mature) Proteins der Alkalischen Protease aus Bacillus lentus DSM 5483 verwendet, die in der internationalen Offenlegungsschrift WO 91/02792 A1 offenbart ist und eine Länge von 269 Aminosäureresten aufweist (in der vorliegenden Anmeldung bezeichnet als Alkalischen Protease aus Bacillus lentus).For the following subjects of the invention, the amino acid sequence of the mature protein of the alkaline protease from Bacillus lentus DSM 5483 is used for determining the position, which is described in International Published Patent Application WO 91/02792 A1 and has a length of 269 amino acid residues (referred to in the present application as Bacillus lentus alkaline protease).

In einer weiteren Ausführungsform der Erfindung ist das Wasch- oder Reinigungsmittel dadurch gekennzeichnet, dass die Protease aus einer Ausgangsprotease durch mindestens eine Veränderung einer Aminosäure erhalten wurde, wobei die Veränderung eine Substitution oder Insertion einer Aminosäure in demjenigen Bereich der Aminosäuresequenz ist, der den Positionen 95 bis 103 der Alkalischen Protease aus Bacillus lentus in einem Alignment zugeordnet ist.In a further embodiment of the invention, the washing or cleaning agent is characterized in that the protease was obtained from an initial protease by at least one change of an amino acid, the change being a substitution or insertion of an amino acid in that region of the amino acid sequence corresponding to the positions 95 to 103 of the alkaline protease from Bacillus lentus is assigned in an alignment.

Besonders bevorzugt handelt es sich bei einer solchen Protease-Variante um eine Variante mit einer Insertion einer einzelnen Aminosäure nach einer oder mehrerer der Positionen 95, 96, 97, 98, 99, 100, 101, 102 und/oder 103 und ganz besonders bevorzugt zwischen den Positionen 97 und 98 und/oder den Positionen 99 und 100.Such a protease variant is particularly preferably a variant with an insertion of a single amino acid according to one or more of the positions 95, 96, 97, 98, 99, 100, 101, 102 and / or 103 and very particularly preferably between positions 97 and 98 and / or positions 99 and 100.

In einer weiteren Ausführungsform der Erfindung ist das Wasch- oder Reinigungsmittel dadurch gekennzeichnet, dass die Protease aus einer Ausgangsprotease durch mindestens eine Veränderung einer Aminosäure erhalten wurde, die den Positionen 3, 4, 36, 42, 43, 47, 56, 61, 69, 87, 96, 99, 101, 102, 104, 114, 118, 120, 130, 139, 141, 142, 154, 157, 188, 193, 199, 205, 211, 224, 229, 236, 237, 242, 243, 250, 253, 255 und 268 der Alkalischen Protease aus Bacillus lentus in einem Alignment zugeordnet sind, wobei die Veränderung eine Substitution, Insertion oder Deletion einer Aminosäure ist.In a further embodiment of the invention, the washing or cleaning agent is characterized in that the protease has been obtained from an initial protease by at least one modification of an amino acid which corresponds to the positions 3, 4, 36, 42, 43, 47, 56, 61, 69 , 87, 96, 99, 101, 102, 104, 114, 118, 120, 130, 139, 141, 142, 154, 157, 188, 193, 199, 205, 211, 224, 229, 236, 237, 242 , 243, 250, 253, 255 and 268 of the Bacillus lentus alkaline protease in an alignment, wherein the alteration is a substitution, insertion or deletion of an amino acid.

Besonders bevorzugt erfolgt eine Aminosäureänderung gegenüber dem Ausgangsmolekül in einer oder mehreren der folgenden Positionen: 3, 4, 43, 61, 188, 193, 199, 211, 224, 250 und 253 (Zählung gemäß der Alkalischen Protease aus Bacillus lentus), besonders bevorzugt mit einem oder mehreren der Aminosäureaustausche X3T, X4I, X43V, X61A, X188P, X193M, X199I, X211L, X211D, X211E, X211G, X211N oder X211Q, X224V, X250G und/oder X253N. Insbesondere handelt es sich bei der Protease um eine Variante mit einer Punktmutation in Position 211, vorzugsweise mit einer Substitution einer einzelnen Aminosäure in dieser Position, besonders bevorzugt mit der Aminosäuresubstitution X211 L. Die vorstehenden Positionsangaben beziehen sich wiederum auf diejenigen Aminosäurereste, die den genannten Positionen der Alkalischen Protease aus Bacillus lentus in einem Alignment zugeordnet sind.More preferably, an amino acid change relative to the parent molecule occurs in one or more of the following positions: 3, 4, 43, 61, 188, 193, 199, 211, 224, 250 and 253 (count according to Bacillus lentus alkaline protease), more preferably with one or more of the amino acid substitutions X3T, X4I, X43V, X61A, X188P, X193M, X199I, X211L, X211D, X211E, X211G, X211N or X211Q, X224V, X250G and / or X253N. In particular, the protease is a variant with a point mutation in position 211, preferably with a substitution of a single amino acid in this position, particularly preferably with the amino acid substitution X211 L. The above position information relate turn to those amino acid residues that are assigned to the said positions of the alkaline protease from Bacillus lentus in an alignment.

Erfindungsgemäße Wasch- oder Reinigungsmittel können ausschließlich ein Enzym enthalten. Alternativ können sie auch weitere Enzyme in einer für die Wirksamkeit des Mittels zweckmäßigen Konzentration enthalten. Einen weiteren Gegenstand der Erfindung stellen somit Mittel dar, die ferner eines oder mehrere weitere Enzyme umfassen, wobei prinzipiell alle im Stand der Technik für diese Zwecke etablierten Enzyme einsetzbar sind. Als weitere Enzyme bevorzugt einsetzbar sind alle Enzyme, die in dem erfindungsgemäßen Mittel eine katalytische Aktivität entfalten können, insbesondere Proteasen, Amylasen, Cellulasen, Hemicellulasen, Mannanasen, Tannasen, Xylanasen, Xanthanasen, β-Glucosidasen, Carrageenasen, Oxidasen, Oxidoreduktasen, Lipasen oder Esterasen sowie vorzugsweise deren Gemische. Bei der Cellulase handelt es sich vorzugsweise um ein Cellulase-Gemisch oder eine Einkomponentencellulase, vorzugsweise bzw. überwiegend um eine Endoglucanase und/oder eine Cellobiohydrolase. Bei der Oxidoreduktase handelt es sich vorzugsweise um eine Oxidase, insbesondere eine Cholin-Oxidase, oder um eine Perhydrolase.Detergents or cleaning agents according to the invention may contain only one enzyme. Alternatively, they may also contain other enzymes in a concentration effective for the effectiveness of the agent. A further subject of the invention thus represents agents which further comprise one or more further enzymes, wherein in principle all enzymes established in the prior art for these purposes can be used. Other enzymes which can be used as further enzymes are all enzymes which can develop catalytic activity in the agent according to the invention, in particular proteases, amylases, cellulases, hemicellulases, mannanases, tannases, xylanases, xanthanases, β-glucosidases, carrageenases, oxidases, oxidoreductases, lipases or esterases and preferably mixtures thereof. The cellulase is preferably a cellulase mixture or a one-component cellulase, preferably or predominantly an endoglucanase and / or a cellobiohydrolase. The oxidoreductase is preferably an oxidase, in particular a choline oxidase, or a perhydrolase.

Diese Enzyme sind im Prinzip natürlichen Ursprungs; ausgehend von den natürlichen Molekülen stehen für den Einsatz in Wasch- und Reinigungsmitteln aber auch verbesserte Varianten zur Verfügung, die entsprechend bevorzugt eingesetzt werden. Erfindungsgemäße Mittel enthalten Enzyme vorzugsweise in Gesamtmengen von 1 x 10-8 bis 5 Gewichts-Prozent bezogen auf aktives Protein. Bevorzugt sind die Enzyme von 0,001 bis 5 Gew.-%, weiter bevorzugt von 0,01 bis 5 Gew.-%, noch weiter bevorzugt von 0,05 bis 4 Gew.-% und besonders bevorzugt von 0,075 bis 3,5 Gew.-% in erfindungsgemäßen Mitteln enthalten, wobei jedes enthaltene Enzym in den genannten Mengenverhältnissen vorliegen kann.These enzymes are basically of natural origin; but starting from the natural molecules, improved variants are also available for use in detergents and cleaners, which are preferably used accordingly. Agents according to the invention preferably contain enzymes in total amounts of 1 × 10 -8 to 5 percent by weight, based on active protein. Preferably, the enzymes are from 0.001 to 5% by weight, more preferably from 0.01 to 5% by weight, even more preferably from 0.05 to 4% by weight and most preferably from 0.075 to 3.5% by weight. % contained in agents according to the invention, wherein each enzyme contained can be present in the stated proportions.

Die Proteinkonzentration kann mit Hilfe bekannter Methoden, zum Beispiel dem BCA-Verfahren (Bicinchoninsäure; 2,2'-Bichinolyl-4,4'-dicarbonsäure) oder dem Biuret-Verfahren ( A. G. Gornall, C. S. Bardawill und M.M. David, J. Biol. Chem., 177 (1948), S. 751-766 ) bestimmt werden. Besonders bevorzugt unterstützen die weiteren Enzyme die Wirkung des Mittels, beispielsweise die Reinigungsleistung eines Wasch- oder Reinigungsmittels, hinsichtlich bestimmter Anschmutzungen oder Flecken. Besonders bevorzugt zeigen die Enzyme synergistische Effekte hinsichtlich ihrer Wirkung gegenüber bestimmter Anschmutzungen oder Flecken, d.h. die in der Mittelzusammensetzung enthaltenen Enzyme unterstützen sich in ihrer Reinigungsleistung gegenseitig. Synergistische Effekte können nicht nur zwischen verschiedenen Enzymen, sondern auch zwischen einem oder mehreren Enzymen und weiteren Inhaltsstoffen des erfindungsgemäßen Mittels auftreten.The protein concentration can be determined by known methods, for example the BCA method (bicinchoninic acid, 2,2'-biquinolyl-4,4'-dicarboxylic acid) or the biuret method ( Gornall AG, CS Bardawill and MM David, J. Biol. Chem., 177 (1948), pp. 751-766 ). The further enzymes particularly preferably support the effect of the agent, for example the cleaning performance of a washing or cleaning agent, with regard to certain stains or stains. Particularly preferably, the enzymes show synergistic effects with respect to their action against certain stains or stains, ie the enzymes contained in the middle composition mutually support each other in their cleaning performance. Synergistic effects can occur not only between different enzymes, but also between one or more enzymes and other ingredients of the composition according to the invention.

Die in erfindungsgemäßen Mitteln eingesetzten Enzyme stammen entweder ursprünglich aus Mikroorganismen, etwa der Gattungen Bacillus, Streptomyces, Humicola, oder Pseudomonas, und/oder werden nach an sich bekannten biotechnologischen Verfahren durch geeignete Mikroorganismen produziert, beispielsweise durch transgene Expressionswirte der Gattungen Bacillus oder durch filamentöse Fungi.The enzymes used in agents of the invention are either originally from microorganisms, such as the genera Bacillus, Streptomyces, Humicola, or Pseudomonas, and / or are produced by biotechnological methods known per se by suitable microorganisms, for example by transgenic expression hosts of the genera Bacillus or by filamentous fungi ,

In erfindungsgemäßen Mitteln wird das Enzym bzw. die Enzyme sowie die stabilisierende Verbindung vorzugsweise mit einzelnen oder mehreren der folgenden Inhaltsstoffe kombiniert: nichtionische, anionische und/oder kationische Tenside, Bleichmittel, Bleichaktivatoren, Bleichkatalysatoren, Builder und/oder Cobuilder, Säuren, alkalische Substanzen, Hydrotropen, Lösungsmittel, Verdicker, Sequestrierungsmittel, Elektrolyte, optische Aufheller, Vergrauungsinhibitoren, Korrosionsinhibitoren, insbesondere Silberschutzmittel (Silberkorrosionsinhibitoren), Soil-Release-Wirkstoffe, Farbtransfer (oder -Übertragungs) -Inhibitoren, Schaum¬inhibitoren, Abrasivstoffe, Farbstoffe, Duftstoffe, Parfums, antimikrobielle Wirkstoffe, UV-Schutzmittel bzw. -Absorbenzien, Antistatika, Perlglanzmitteln und Hautschutzmitteln, weitere Stabilisatoren, insbesondere Enzymstabilisatoren, und andere Komponenten, die aus dem Stand der Technik bekannt sind. Einen weiteren Gegenstand der Erfindung stellen somit Wasch- oder Reinigungsmittel dar, die dadurch gekennzeichnet, dass sie mindestens eine weitere Komponente enthalten, die ausgewählt ist aus der Gruppe bestehend aus Tensiden, Buildern, Säuren, alkalischen Substanzen, Hydrotropen, Lösungsmitteln, Verdickungsmitteln, Bleichmitteln, Farbstoffen, Parfums, Korrosionsinhibitoren, Sequestriermitteln, Elektrolyten, optischen Aufhellern, Vergrauungsinhibitoren, Silberkorrosionsinhibitoren, Farbübertragungsinhibitoren, Schauminhibitoren, Abrasivstoffen, UV-Absorbenzien, Lösungsmitteln, Antistatika, Perlglanzmitteln und Hautschutzmitteln. Erfindungsgemäße Mittel enthalten vorzugsweise mindestens einen Komplexbildner und/oder Buildersubstanzen, wobei es sich bei dem Builder insbesondere um einen Zeolith-Builder handelt, und/oder ein nichtionisches Tensid, wobei es sich bei dem nichtionischen Tensid vorzugsweise um einen Hydroxymischether handelt, und/oder optischen Aufheller, wobei es sich bei dem optischen Aufheller um Diphenylverbindungen, insbesondere um Distyryl-Biphenylderivate, und/oder um Stilbentriazin-Derivate handelt.In agents according to the invention, the enzyme (s) and the stabilizing compound are preferably combined with one or more of the following ingredients: nonionic, anionic and / or cationic surfactants, bleaches, bleach activators, bleach catalysts, builders and / or cobuilders, acids, alkaline substances, Hydrotropes, solvents, thickeners, sequestering agents, electrolytes, optical brighteners, grayness inhibitors, corrosion inhibitors, in particular silver protectants (silver corrosion inhibitors), soil release agents, color transfer (or transfer) inhibitors, foam inhibitors, abrasives, dyes, fragrances, perfumes, antimicrobial agents, UV protectants or absorbents, antistatic agents, pearlescing agents and skin protection agents, further stabilizers, in particular enzyme stabilizers, and other components known from the prior art. A further subject of the invention therefore is washing or cleaning agents which are characterized in that they contain at least one further component which is selected from the group consisting of surfactants, builders, acids, alkaline substances, hydrotropes, solvents, thickeners, bleaching agents, Dyes, perfumes, corrosion inhibitors, sequestering agents, electrolytes, optical brighteners, grayness inhibitors, silver corrosion inhibitors, dye transfer inhibitors, foam inhibitors, abrasives, UV absorbers, solvents, antistatic agents, pearlescers and skin protection agents. Agents according to the invention preferably comprise at least one complexing agent and / or builder substances, the builder being in particular a zeolite builder, and / or a nonionic surfactant, the nonionic surfactant preferably being a hydroxy mixed ether, and / or optical Brightener, wherein the optical brightener is diphenyl compounds, in particular distyryl biphenyl derivatives, and / or stilbentriazine derivatives.

Die zu wählenden Inhaltsstoffe wie auch die Bedingungen, unter denen das Mittel eingesetzt wird, wie beispielsweise Temperatur, pH-Wert, Ionenstärke, Redox-Verhältnisse oder mechanische Einflüsse, sollten für das jeweilige Reinigungsproblem optimiert sein. So liegen übliche Temperaturen für Wasch- und Reinigungsmittel in Bereichen von 10°C bei manuellen Mitteln über 20°C, 30°C, 40°C und 60°C bis hin zu 95° bei maschinellen Mitteln oder bei technischen Anwendungen. Da bei modernen Wasch- und Spülmaschinen die Temperatur meist stufenlos einstellbar ist, sind auch alle Zwischenstufen der Temperatur eingeschlossen. Vorzugsweise werden die Inhaltsstoffe der betreffenden Mittel aufeinander abgestimmt. Bevorzugt sind Synergien hinsichtlich der Reinigungsleistung. Besonders bevorzugt diesbezüglich sind Synergien, die in einem Temperaturbereich zwischen 20°C und 60°C vorhanden sind, da auch das in den erfindungsgemäßen Mitteln enthaltene Enzym bzw. die enthaltenen Enzyme in diesem Temperaturbereich katalytisch aktiv sind.The ingredients to be selected as well as the conditions under which the agent is used, such as temperature, pH, ionic strength, redox ratios or mechanical influences, should be optimized for the respective cleaning problem. For example, the usual temperatures for detergents and cleaners in the range of 10 ° C for manual agents over 20 ° C, 30 ° C, 40 ° C and 60 ° C up to 95 ° for mechanical means or in technical applications. Since the temperature is usually infinitely adjustable in modern washing machines and dishwashers, all intermediate stages of the temperature are included. Preferably, the ingredients of the respective agents are coordinated. Synergies are preferred in terms of cleaning performance. Particularly preferred in this regard are synergies which are present in a temperature range between 20.degree. C. and 60.degree. C., since the enzyme or the enzymes contained in the agents according to the invention are also catalytically active in this temperature range.

In einer weiteren Ausführungsform der Erfindung ist das Wasch- oder Reinigungsmittel dadurch gekennzeichnet, dass es mindestens einen weiteren Stabilisator enthält. In einem solchen Mittel sind daher mindestens zwei Verbindungen vorhanden, die eine Stabilisierung eines enthaltenen Enzyms, vorzugsweise einer Protease, bewirken. Bevorzugt wirken diese Verbindungen synergistisch, d.h. die durch beide Verbindungen erreichte Stabilisierungswirkung übersteigt die Summe der beiden einzelnen Stabilisierungswirkungen. In einer bevozugten Ausführungsform handelt es sich bei dem/den Stabilisator(en) um ein oder mehrere Polyole, insbesondere um Glycerin oder 1,2-Ethylenglycol, um ein Antioxidans, um Lactat oder ein oder mehrere Lactatderivate oder Kombinationen hiervon. Ebenfalls bevorzugt handelt es sich um eine oder mehrere derjenigen enzymstabilisierenden bzw. -inhibierenden Verbindungen, die in den internationalen Patentanmeldungen WO 07/113241 A1 oder WO 02/008398 offenbart sind.In a further embodiment of the invention, the washing or cleaning agent is characterized in that it contains at least one further stabilizer. In such an agent, therefore, there are at least two compounds which cause stabilization of a contained enzyme, preferably a protease. Preferably, these compounds act synergistically, ie the stabilization effect achieved by both compounds exceeds the sum of the two individual stabilization effects. In a preferred embodiment, the stabilizer (s) is one or more polyols, in particular glycerol or 1,2-ethylene glycol, an antioxidant, lactate or one or more lactate derivatives or combinations thereof. It is likewise preferably one or more of those enzyme-stabilizing or inhibiting compounds which are described in the international patent applications WO 07/113241 A1 or WO 02/008398 are disclosed.

Ein weiterer Gegenstand der Erfindung ist die Verwendung einer Verbindung der allgemeinen Strukturformel

Figure imgb0007
in der X ein aliphatischer oder ein aromatischer Rest ist und Y ein aliphatischer oder ein aromatischer Rest ist, als reversibler Inhibitor eines Enzyms in einem Wasch- oder Reinigungsmittel. Denn wie vorstehend bereits ausgeführt, bewirken diese Verbindungen auf Grund ihres Wirkmechanismus als reversibler Inhibitor eine vorteilhafte Stabilisierung des Enzyms in dem Wasch- oder Reinigungsmittel. In einer bevorzugten Ausführungsform der Erfindung ist die Verwendung dadurch gekennzeichnet, dass die Reste X und Y identisch sind. In einer weiteren bevorzugten Ausführungsform der Erfindung ist die Verwendung dadurch gekennzeichnet, dass der Rest X ausgewählt ist aus der Gruppe bestehend aus: -CH2-CH2-CH3, Phenyl. In einer weiteren Ausführungsform der Erfindung ist die Verwendung dadurch gekennzeichnet, dass der Rest Y ausgewählt ist aus der Gruppe bestehend aus: -CH2-CH2-CH3, Phenyl.Another object of the invention is the use of a compound of the general structural formula
Figure imgb0007
wherein X is an aliphatic or an aromatic radical and Y is an aliphatic or an aromatic radical, as a reversible inhibitor of an enzyme in a washing or cleaning agent. Because, as already stated above, cause these compounds due to their mechanism of action as a reversible inhibitor advantageous stabilization of the enzyme in the washing or cleaning agent. In a preferred embodiment of the invention, the use is characterized in that the radicals X and Y are identical. In a further preferred embodiment of the invention, the use is characterized in that the radical X is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl. In a further embodiment of the invention, the use is characterized in that the radical Y is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl.

In einer weiteren bevorzugten Ausführungsform dieses Erfindungsgegenstands ist das Enzym ausgewählt aus der Gruppe bestehend aus: Protease, Amylase, Cellulase, Hemicellulase, Mannanase, Tannase, Xylanase, Xanthanase, β-Glucosidase, Carrageenase, Oxidase, Oxidoreduktase, Lipase, Esterase oder Mischungen hiervon. Besonders bevorzugt handelt es sich bei dem Enzym um eine Protease, bevorzugt eine Serinprotease, weiter bevorzugt eine Subtilase und besonders bevorzugt ein Subtilisin.In a further preferred embodiment of this subject of the invention, the enzyme is selected from the group consisting of: protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, β-glucosidase, carrageenase, oxidase, Oxidoreductase, lipase, esterase or mixtures thereof. The enzyme is particularly preferably a protease, preferably a serine protease, more preferably a subtilase and particularly preferably a subtilisin.

Auf Grund der beschriebenen vorteilhaften erfindungsgemäßen Verwendungen einer solchen Verbindung zur Stabilisierung eines Enzyms in einem Wasch- oder Reinigungsmittel ist eine solche Kombination von Enzym und Stabilisator ebenfalls vorteilhaft einzusetzen bei der Herstellung eines entsprechenden Wasch- oder Reinigungsmittels. Ein weiterer Gegenstand der Erfindung ist daher die Verwendung eines Enzyms und einer Verbindung der allgemeinen Strukturformel

Figure imgb0008
in der X ein aliphatischer oder ein aromatischer Rest ist und Y ein aliphatischer oder ein aromatischer Rest ist, zur Herstellung eines Wasch- oder Reinigungsmittels. Insbesondere handelt es sich bei der Verbindung um eine solche, in der die Reste X und Y identisch sind und/oder der Rest X ausgewählt ist aus der Gruppe bestehend aus: -CH2-CH2-CH3, Phenyl, und/oder der Rest Y ausgewählt ist aus der Gruppe bestehend aus: -CH2-CH2-CH3, Phenyl.Due to the described advantageous uses according to the invention of such a compound for stabilizing an enzyme in a washing or cleaning agent, such a combination of enzyme and stabilizer is likewise advantageously used in the preparation of a corresponding washing or cleaning agent. Another object of the invention is therefore the use of an enzyme and a compound of the general structural formula
Figure imgb0008
wherein X is an aliphatic or an aromatic radical and Y is an aliphatic or an aromatic radical, for the preparation of a washing or cleaning agent. In particular, the compound is one in which the radicals X and Y are identical and / or the radical X is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl, and / or the Rest Y is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl.

In einer bevorzugten Ausführungsform ist dieser Erfindungsgegenstand dadurch gekennzeichnet, dass das Enzym ausgewählt ist aus der Gruppe bestehend aus: Protease, Amylase, Cellulase, Hemicellulase, Mannanase, Tannase, Xylanase, Xanthanase, β-Glucosidase, Carrageenase, Oxidase, Oxidoreduktase, Lipase, Esterase oder Mischungen hiervon. Besonders bevorzugt handelt es sich bei dem Enzym um eine Protease, bevorzugt eine Serinprotease, weiter bevorzugt eine Subtilase und besonders bevorzugt ein Subtilisin.In a preferred embodiment, this invention is characterized in that the enzyme is selected from the group consisting of: protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, β-glucosidase, carrageenase, oxidase, oxidoreductase, lipase, esterase or mixtures thereof. The enzyme is particularly preferably a protease, preferably a serine protease, more preferably a subtilase and particularly preferably a subtilisin.

Ein weiterer Gegenstand der Erfindung ist ein Wasch- oder Reinigungsverfahren, in dem ein Enzym zur Wirkung kommt, welches inhibiert und/oder stabilisiert ist mit einer Verbindung der allgemeinen Strukturformel

Figure imgb0009
in der X ein aliphatischer oder ein aromatischer Rest ist und Y ein aliphatischer oder ein aromatischer Rest ist. Insbesondere handelt es sich bei der Verbindung um eine solche, in der die Reste X und Y identisch sind und/oder der Rest X ausgewählt ist aus der Gruppe bestehend aus: - CH2-CH2-CH3, Phenyl, und/oder der Rest Y ausgewählt ist aus der Gruppe bestehend aus: -CH2-CH2-CH3, Phenyl.Another object of the invention is a washing or cleaning process in which an enzyme acts, which is inhibited and / or stabilized with a compound of the general structural formula
Figure imgb0009
wherein X is an aliphatic or an aromatic radical and Y is an aliphatic or an aromatic radical. In particular, the compound is one in which the radicals X and Y are identical and / or the radical X is selected from the group consisting of: CH 2 -CH 2 -CH 3 , phenyl, and / or the radical Y is selected from the group consisting of: -CH 2 -CH 2 -CH 3 , phenyl.

Denn wie vorstehend bereits ausgeführt, bewirken diese Verbindungen auf Grund ihres Wirkmechanismus als reversibler Inhibitor eine vorteilhafte Stabilisierung des Enzyms in dem Wasch- oder Reinigungsmittel, so dass für das Wasch- oder Reinigungsverfahren eine höhere Enzymaktivität zur Verfügung steht im Vergleich mit einem Wasch- oder Reinigungsmittel, in dem das Enzym nicht stabilisiert war. In einer weiteren bevorzugten Ausführungsform ist dieser Erfindungsgegenstand dadurch gekennzeichnet, dass das Enzym ausgewählt ist aus der Gruppe bestehend aus: Protease, Amylase, Cellulase, Hemicellulase, Mannanase, Tannase, Xylanase, Xanthanase, β-Glucosidase, Carrageenase, Oxidase, Oxidoreduktase, Lipase, Esterase oder Mischungen hiervon. Besonders bevorzugt handelt es sich bei dem Enzym um eine Protease, bevorzugt eine Serinprotease, weiter bevorzugt eine Subtilase und besonders bevorzugt ein Subtilisin.Because, as already stated above, these compounds cause due to their mechanism of action as a reversible inhibitor advantageous stabilization of the enzyme in the washing or cleaning agent, so that for the washing or cleaning process, a higher enzyme activity is available in comparison with a detergent or cleaning agent in which the enzyme was not stabilized. In a further preferred embodiment, this subject matter of the invention is characterized in that the enzyme is selected from the group consisting of: protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, β-glucosidase, carrageenase, oxidase, oxidoreductase, lipase, Esterase or mixtures thereof. The enzyme is particularly preferably a protease, preferably a serine protease, more preferably a subtilase and particularly preferably a subtilisin.

In einer bevorzugten Ausführungsform der Erfindung ist das Wasch- oder Reinigungsverfahren ferner dadurch gekennzeichnet, dass ein erfindungsgemäßes Wasch- oder Reinigungsmittel eingesetzt ist, wie es vorstehend beschrieben ist.In a preferred embodiment of the invention, the washing or cleaning method is further characterized in that a washing or cleaning agent according to the invention is used, as described above.

Aus der vorteilhaften Anwendung erfindungsgemäßer Wasch- oder Reinigungsmittel in Wasch- oder Reinigungsverfahren ergibt sich konsequenterweise, dass die erfindungsgemäßen Wasch- oder Reinigungsmittel für Reinigungszwecke vorteilhaft verwendbar sind. Einen weiteren Gegenstand der Erfindung stellt daher die Verwendung eines Wasch- oder Reinigungsmittels, wie es vorstehend beschrieben ist, zum Waschen und/oder Reinigen von Textilien und/oder harten Oberflächen dar.From the advantageous use of detergents or cleaning agents according to the invention in washing or cleaning processes, it is consequently clear that the washing or cleaning agents according to the invention can advantageously be used for cleaning purposes. A further subject of the invention is therefore the use of a washing or cleaning agent, as described above, for washing and / or cleaning textiles and / or hard surfaces.

Es wird an dieser Stelle ausdrücklich betont, dass alle Sachverhalte, Gegenstände und Ausführungsformen, die für erfindungsgemäße Wasch- oder Reinigungsmittel beschrieben sind, auch auf alle vorstehend genannten erfindungsgemäßen Verwendungen und alle erfindungsgemäßen Verfahren anwendbar sind. Daher wird an dieser Stelle ausdrücklich auf die Offenbarung an entsprechender Stelle verwiesen mit dem Hinweis, dass diese Offenbarung auch für alle vorstehenden erfindungsgemäßen Verwendungen und Verfahren gilt.It is expressly emphasized at this point that all facts, objects and embodiments which are described for washing or cleaning agents according to the invention are also applicable to all abovementioned uses according to the invention and to all methods according to the invention. Therefore, reference is made at this point expressly to the disclosure in the appropriate place with the statement that this disclosure also applies to all above uses and methods according to the invention.

Die nachfolgenden Beispiele erläutern die Erfindung weiter, ohne sie jedoch darauf einzuschränken.The following examples further illustrate the invention without, however, limiting it thereto.

BeispieleExamples Beispiel 1example 1 Untersuchung der Protease-Restaktivität in Gegenwart eines InhibitorsExamination of protease residual activity in the presence of an inhibitor

Zum Nachweis, dass die unten aufgeführten Verbindungen eine die Protease-Aktivität inhibierende Wirkung ausüben und somit eine stabilisierende Wirkung aufweisen, wurde die proteolytische Restaktivität der Bacillus lentus-Alkalische Protease F49 (gemäß WO 95/23221 A1 ) in Anwesenheit dieser Verbindungen ermittelt.To demonstrate that the compounds listed below exert a protease activity-inhibiting action and thus have a stabilizing effect, the residual proteolytic activity of Bacillus lentus alkaline protease F49 (according to US Pat WO 95/23221 A1 ) in the presence of these compounds.

In parallelen Reaktionsansätzen wurden in 100 mM Tris-Puffer, pH 6,8, 0,1% (w/v) BrijTM35 das Substrat Succinyl Alanin-Alanin-Prolin-Phenylalanin-para-Nitroanilid (AAPFpNA; Bachem L-1400) und 5 x 10-9 bzw. 1 x 10-8 M der Protease vorgelegt. Hinzu kamen die nachstehend aufgeführten zu testenden Verbindungen in einer Endkonzentration von 10 mM. Sie waren jeweils in wasserfreiem DMSO gelöst, wobei Effekte von DMSO auf die enzymatische Aktivität über die entsprechende Referenz mit derselben Menge DMSO, aber ohne die betreffende Verbindung, korrigiert wurden. Die Inkubation erfolgte für 5 min bei pH 8,6 und 25°C. Als Vergleich diente der entsprechende Reaktionsansatz mit Protease, aber ohne die betreffende Verbindung. Die Proteaseaktivität in diesen Vergleichsansätzen wurde als 100% gesetzt.In parallel reactions, in 100 mM Tris buffer, pH 6.8, 0.1% (w / v) BrijTM35, the substrate succinyl alanine-alanine-proline-phenylalanine-para-nitroanilide (AAPFpNA; Bachem L-1400) and 5 x 10 -9 and 1 x 10 -8 M of the protease presented. Added to this were the following compounds to be tested in a final concentration of 10 mM. They were each dissolved in anhydrous DMSO, with effects of DMSO on the enzymatic activity being corrected by the corresponding reference with the same amount of DMSO but without the compound in question. The incubation was carried out for 5 min at pH 8.6 and 25 ° C. As a comparison, the corresponding reaction mixture was used with protease, but without the compound in question. The protease activity in these comparisons was set as 100%.

Auf diese Weise wurden folgende Verbindungen untersucht:

  • V1: Dibutylphosphat
  • V2: Dibenzylphosphat
In this way, the following compounds were investigated:
  • V1: dibutyl phosphate
  • V2: dibenzyl phosphate

Die Verbindungen führten zu einer Restaktivität der Protease von weniger als 60%. Hierunter ist V1 der stärkste und damit am besten geeigente Protease-Inhibitor bzw. Stabilisator, gefolgt von V2. Die Restaktivitäten der Protease betrugen 45% für V1 und 56% für V2.The compounds resulted in a residual activity of the protease of less than 60%. Among them, V1 is the strongest and thus most suitable protease inhibitor or stabilizer, followed by V2. The residual activities of the protease were 45% for V1 and 56% for V2.

Aufgrund dieser Ergebnisse sind diese Verbindungen sehr gut geeignet, die enzymatischen Aktivitäten in Protease enthaltenden Wasch- und Reinigungsmitteln während der Lagerung zu stabilisieren.Due to these results, these compounds are very well suited to stabilize the enzymatic activities in protease-containing detergents and cleaning agents during storage.

Beispiel 2Example 2

Untersuchung der Lagerstabilität proteasehaltiger Wasch- und Reinigungsmittel in Gegenwart von erfindungsgemäßen EnzymstabilisatorenInvestigation of the storage stability of protease-containing detergents and cleaners in the presence of enzyme stabilizers according to the invention

Als Basisrezeptur wurde ein Flüssigwaschmittel mit folgender Zusammensetzung angesetzt (alle Angaben in Gewichts-Prozent): 0,3-0,5% Xanthan Gum, 0,2-0,4% Anti-Schaummittel, 6-7% Glycerin, 0,3-0,5% Ethanol, 4-7% FAEOS, 24-28% Nichtionische Tenside, 1% Borsäure, 1-2% Natriumcitrat (Dihydrat), 2-4% Soda, 14-16% Kokosnuss-Fettsäuren, 0,5% HEDP, 0-0,4% PVP, 0-0,05% optischer Aufheller, 0-0,001 % Farbstoff, Rest: demineralisiertes Wasser.As a base formulation, a liquid detergent was prepared with the following composition (all figures in percent by weight): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7% glycerol, 0.3 -0.5% ethanol, 4-7% FAEOS, 24-28% nonionic surfactants, 1% boric acid, 1-2% sodium citrate (dihydrate), 2-4% soda, 14-16% coconut fatty acids, 0.5 % HEDP, 0-0.4% PVP, 0-0.05% optical brightener, 0-0.001% dye, balance: demineralized water.

Diese Rezeptur wurde mit den zu testenden, inhibierenden Verbindungen gemäß Beispiel 1 und 1.275.000 HPE/I B. lentus-Alkalische Protease F 49 versetzt. Die in HPE angegebene Protease-Aktivität (Henkel-Protease-Einheiten) wurde nach van Raay, Saran und Verbeek, gemäß der Veröffenlichung " Zur Bestimmung der proteolytischen Aktivität in Enzymkonzentraten und enzymhaltigen Wasch-, Spül- und Reinigungsmitteln" in Tenside (1970), Band 7, S. 125 - 132 , bestimmt.This formulation was admixed with the inhibiting compounds of Example 1 to be tested and 1,275,000 HPE / I B. lentus alkaline protease F 49. The protease activity (Henkel protease units) reported in HPE was calculated after van Raay, Saran and Verbeek, according to the publication " For the determination of the proteolytic activity in enzyme concentrates and enzyme-containing detergents, dishwashing detergents and cleaners "in Tenside (1970), Volume 7, pp. 125-132 , certainly.

Die Lagerung erfolgte über verschieden lange Zeiträume in luftdicht verschlossenen Gefäßen bei 30°C.The storage took place for different lengths of time in airtight containers at 30 ° C.

Zur Auswertung wurden die Anfangswerte für die proteolytische Aktivität des betreffenden Mittels mit den nach der Lagerung bestimmten Werten verglichen. Je höher die nach der Lagerung verbleibende Aktivität war, desto besser war die enthaltene Protease während der Lagerung inaktiviert und desto besser eignet sich die betreffende Verbindung als erfindungsgemäßer Stabilisator.For evaluation, the initial values for the proteolytic activity of the agent in question were compared with the values determined after storage. The higher the activity remaining after storage, the better the protease contained was inactivated during storage and the better the compound in question is suitable as a stabilizer according to the invention.

Alle untersuchten Verbindungen zeigten eine eindeutig stabilisierende Wirkung.All investigated compounds showed a clearly stabilizing effect.

Claims (15)

  1. A washing or cleaning agent containing an enzyme and a compound of the general structural formula
    Figure imgb0014
    in which X is an aliphatic or an aromatic residue, and Y is an aliphatic or an aromatic residue, wherein residue X is selected from the group consisting of: -CH2-CH2-CH3, phenyl, in particular one in which the residues X and Y are identical, and/or the residue Y is selected from the group consisting of: -CH2-CH2-CH3, phenyl.
  2. The washing or cleaning agent according to Claim 1, characterized in that the compound has, with respect to the enzyme, an inhibition constant (Ki) from 0.01 to 10 mM, in particular an inhibition constant (Ki) from 0.03 to 5 mM.
  3. The washing or cleaning agent according to one of Claims 1 or 2, characterized in that the enzyme is contained at a concentration from 2 µg to 20 mg per gram of the agent, preferably from 5 µg to 17.5 mg per g of the agent, more preferably from 20 µg to 15 mg per g of the agent, particularly preferably from 50 µg to 10 mg of the agent,
    and/or in that the compound is contained at a concentration of up to 50 mg per g of the agent, preferably up to 10 mg, more preferably up to 7 mg, particularly preferably up to 5 mg per gram of the agent,
    and/or in that the molar ratio of the compound to the enzyme is from 1:1 to 1,000:1, preferably from 1:1 to 500:1, more preferably from 1:1 to 100:1, particularly preferably from 1:1 to 20:1.
  4. The washing or cleaning agent according to one of Claims 1 to 3, characterized in that the quantity of the compound contained in the agent, based on the stabilized enzyme, is from 0.01 to 100 times the inhibition constant Ki, preferably 0.1 to 10 times Ki, more preferably 1 to 5 times Ki.
  5. The washing or cleaning agent according to one of Claims 1 to 4 in predominantly solid form, or in predominantly liquid, pasty, or gel form.
  6. The washing or cleaning agent according to one of Claims 1 to 5, characterized in that the enzyme is selected from the group consisting of: protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, β-glucosidase, carrageenase, oxidase, oxidoreductase, lipase, esterase, or mixtures thereof.
  7. The washing or cleaning agent according to one of Claims 1 to 6, characterized in that the enzyme is a protease, preferably a serine protease, more preferably a subtilase, and particularly preferably a subtilisin.
  8. The washing or cleaning agent according to Claim 7, characterized in that the protease was obtained from an initial protease by means of at least one modification of an amino acid, the modification being a substitution, insertion, or deletion of an amino acid, and it is at least 90%, preferably at least 92.5%, more preferably at least 95%, and particularly preferably at least 97.5% identical to the initial protease at the amino acid level,
    and/or in that the protease was obtained from an initial protease by means of at least one modification of an amino acid, the modification being a substitution or insertion of an amino acid in that region of the amino acid sequence that is associated, in an alignment, with positions 95 to 103 of the alkaline protease from Bacillus lentus,
    and/or in that the protease was obtained from an initial protease by means of at least one modification of an amino acid that are associated,
    in an alignment, with positions 3, 4, 36, 42, 43, 47, 56, 61, 69, 87, 96, 99, 101, 102, 104, 114, 118, 120, 130, 139, 141, 142, 154, 157, 188, 193, 199, 205, 211, 224, 229, 236, 237, 242, 243, 250, 253, 255, and 268 of the alkaline protease from Bacillus lentus, the modification being a substitution, insertion, or deletion of an amino acid.
  9. The washing or cleaning agent according to one of Claims 1 to 8, characterized in that it contains at least one further stabilizer, in particular one that involves one or more polyols, in particular glycerol or 1,2-ethylene glycol, an antioxidant, lactate or one or more lactate derivatives, or combinations thereof.
  10. Use of a compound of the general structural formula
    Figure imgb0015
    in which X is an aliphatic or an aromatic residue, and Y is an aliphatic or an aromatic residue, wherein residue X is selected from the group consisting of: -CH2-CH2-CH3, phenyl, as a reversible inhibitor of an enzyme in a washing or cleaning agent, in particular in one in which the residues X and Y are identical, and/or the residue Y is selected from the group made up of: -CH2-CH2-CH3, phenyl.
  11. Use of an enzyme, in particular of one that is selected from the group consisting of protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, β-glucosidase, carrageenase, oxidase, oxidoreductase, lipase, esterase, or mixtures thereof, and of a compound of the general structural formula
    Figure imgb0016
    in which X is an aliphatic or an aromatic residue, and Y is an aliphatic or an aromatic residue, wherein residue X is selected from the group made up of: -CH2-CH2-CH3, phenyl, to manufacture a washing or cleaning agent, in particular one in which the residues X and Y are identical, and/or the residue Y is selected from the group made up of: -CH2-CH2-CH3, phenyl.
  12. The use according to Claim 11, characterized in that the enzyme is a protease, preferably a serine protease, more preferably a subtilase, and particularly preferably a subtilisin.
  13. A washing or cleaning method in which an enzyme, in particular one that is selected from the group consisting of protease, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, β-glucosidase, carrageenase, oxidase, oxidoreductase, lipase, esterase, or mixtures thereof, is effective, which is inhibited and/or stabilized with a compound of the general structural formula
    Figure imgb0017
    in which X is an aliphatic or an aromatic residue, and Y is an aliphatic or an aromatic residue, wherein residue X is selected from the group consisting of: -CH2-CH2-CH3, phenyl, in particular one in which the residues X and Y are identical, and/or the residue Y is selected from the group consisting of: -CH2-CH2-CH3, phenyl.
  14. A washing or cleaning method, characterized in that a washing or cleaning agent according to one of Claims 1 to 9 is used.
  15. Use of a washing or cleaning agent according to one of Claims 1 to 9 to wash and/or clean textiles and/or hard surfaces.
EP08853177.7A 2007-11-28 2008-11-24 Washing agent having stabilized enzymes Not-in-force EP2220204B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007057583A DE102007057583A1 (en) 2007-11-28 2007-11-28 Detergents with stabilized enzymes
PCT/EP2008/066084 WO2009068501A1 (en) 2007-11-28 2008-11-24 Washing agent having stabilized enzymes

Publications (2)

Publication Number Publication Date
EP2220204A1 EP2220204A1 (en) 2010-08-25
EP2220204B1 true EP2220204B1 (en) 2013-12-25

Family

ID=40344941

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08853177.7A Not-in-force EP2220204B1 (en) 2007-11-28 2008-11-24 Washing agent having stabilized enzymes

Country Status (4)

Country Link
US (1) US8466098B2 (en)
EP (1) EP2220204B1 (en)
DE (1) DE102007057583A1 (en)
WO (1) WO2009068501A1 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012012096A (en) 2010-04-26 2012-12-17 Novozymes As Enzyme granules.
EP2721137B1 (en) 2011-06-20 2017-11-01 Novozymes A/S Particulate composition
US20140206594A1 (en) 2011-06-24 2014-07-24 Martin Simon Borchert Polypeptides Having Protease Activity and Polynucleotides Encoding Same
DK3543333T3 (en) 2011-06-30 2022-02-14 Novozymes As METHOD FOR SCREENING ALFA AMYLASES
EP2732018B1 (en) 2011-07-12 2017-01-04 Novozymes A/S Storage-stable enzyme granules
JP2014531895A (en) 2011-08-15 2014-12-04 ノボザイムス アクティーゼルスカブ Polypeptide having cellulase activity and polynucleotide encoding the same
ES2628190T3 (en) 2011-09-22 2017-08-02 Novozymes A/S Polypeptides with protease activity and polynucleotides encoding them
JP2015500006A (en) 2011-11-25 2015-01-05 ノボザイムス アクティーゼルスカブ Subtilase variant and polynucleotide encoding the same
MX2014007446A (en) 2011-12-20 2014-08-01 Novozymes As Subtilase variants and polynucleotides encoding same.
EP2807254B1 (en) 2012-01-26 2017-08-02 Novozymes A/S Use of polypeptides having protease activity in animal feed and detergents
US10093911B2 (en) 2012-02-17 2018-10-09 Novozymes A/S Subtilisin variants and polynucleotides encoding same
EP2823026A1 (en) 2012-03-07 2015-01-14 Novozymes A/S Detergent composition and substitution of optical brighteners in detergent compositions
US9458441B2 (en) 2012-05-07 2016-10-04 Novozymes A/S Polypeptides having xanthan degrading activity and polynucleotides encoding same
BR112014031882A2 (en) 2012-06-20 2017-08-01 Novozymes As use of an isolated polypeptide, polypeptide, composition, isolated polynucleotide, nucleic acid construct or expression vector, recombinant expression host cell, methods for producing a polypeptide, for enhancing the nutritional value of an animal feed, and for the treatment of protein, use of at least one polypeptide, animal feed additive, animal feed, and detergent composition
EP2934177B1 (en) 2012-12-21 2017-10-25 Novozymes A/S Polypeptides having protease activiy and polynucleotides encoding same
US9902946B2 (en) 2013-01-03 2018-02-27 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
EP2997143A1 (en) 2013-05-17 2016-03-23 Novozymes A/S Polypeptides having alpha amylase activity
CN114634921A (en) 2013-06-06 2022-06-17 诺维信公司 Alpha-amylase variants and polynucleotides encoding same
EP3013956B1 (en) 2013-06-27 2023-03-01 Novozymes A/S Subtilase variants and polynucleotides encoding same
WO2014207224A1 (en) 2013-06-27 2014-12-31 Novozymes A/S Subtilase variants and polynucleotides encoding same
KR20160029080A (en) 2013-07-04 2016-03-14 노보자임스 에이/에스 Polypeptides with xanthan lyase activity having anti-redeposition effect and polynucleotides encoding same
EP3309249B1 (en) 2013-07-29 2019-09-18 Novozymes A/S Protease variants and polynucleotides encoding same
EP2832853A1 (en) 2013-07-29 2015-02-04 Henkel AG&Co. KGAA Detergent composition comprising protease variants
EP3027748B1 (en) 2013-07-29 2019-09-18 Novozymes A/S Protease variants and polynucleotides encoding same
WO2015049370A1 (en) 2013-10-03 2015-04-09 Novozymes A/S Detergent composition and use of detergent composition
EP3083954B1 (en) 2013-12-20 2018-09-26 Novozymes A/S Polypeptides having protease activity and polynucleotides encoding same
CN106062271A (en) 2014-03-05 2016-10-26 诺维信公司 Compositions and methods for improving properties of cellulosic textile materials with xyloglucan endotransglycosylase
EP3114219A1 (en) 2014-03-05 2017-01-11 Novozymes A/S Compositions and methods for improving properties of non-cellulosic textile materials with xyloglucan endotransglycosylase
WO2015150457A1 (en) 2014-04-01 2015-10-08 Novozymes A/S Polypeptides having alpha amylase activity
US20170121695A1 (en) 2014-06-12 2017-05-04 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
CA2950380A1 (en) 2014-07-04 2016-01-07 Novozymes A/S Subtilase variants and polynucleotides encoding same
US10626388B2 (en) 2014-07-04 2020-04-21 Novozymes A/S Subtilase variants and polynucleotides encoding same
US10287562B2 (en) 2014-11-20 2019-05-14 Novoszymes A/S Alicyclobacillus variants and polynucleotides encoding same
MX2017006695A (en) 2014-12-04 2017-08-21 Novozymes As Subtilase variants and polynucleotides encoding same.
ES2763235T3 (en) 2014-12-15 2020-05-27 Henkel Ag & Co Kgaa Detergent composition comprising subtilase variants
EP3872175A1 (en) 2015-06-18 2021-09-01 Novozymes A/S Subtilase variants and polynucleotides encoding same
EP3106508B1 (en) 2015-06-18 2019-11-20 Henkel AG & Co. KGaA Detergent composition comprising subtilase variants
EP4324919A2 (en) 2015-10-14 2024-02-21 Novozymes A/S Polypeptide variants
US20180171318A1 (en) 2015-10-14 2018-06-21 Novozymes A/S Polypeptides Having Protease Activity and Polynucleotides Encoding Same
WO2017207762A1 (en) 2016-06-03 2017-12-07 Novozymes A/S Subtilase variants and polynucleotides encoding same
WO2018011277A1 (en) 2016-07-13 2018-01-18 Novozymes A/S Bacillus cibi dnase variants
EP3476935B1 (en) 2017-10-27 2022-02-09 The Procter & Gamble Company Detergent compositions comprising polypeptide variants
BR112020008251A2 (en) 2017-10-27 2020-11-17 Novozymes A/S dnase variants
US20210009927A1 (en) 2018-04-17 2021-01-14 Novozymes A/S Polypeptides Comprising Carbohydrate Binding Activity in Detergent Compositions And Their use in Reducing Wrinkles in Textile or Fabrics
AU2020242303A1 (en) 2019-03-21 2021-06-24 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
WO2020207944A1 (en) 2019-04-10 2020-10-15 Novozymes A/S Polypeptide variants
EP4022019A1 (en) 2019-08-27 2022-07-06 Novozymes A/S Detergent composition
EP4031644A1 (en) 2019-09-19 2022-07-27 Novozymes A/S Detergent composition
WO2021064068A1 (en) 2019-10-03 2021-04-08 Novozymes A/S Polypeptides comprising at least two carbohydrate binding domains
EP3892708A1 (en) 2020-04-06 2021-10-13 Henkel AG & Co. KGaA Cleaning compositions comprising dispersin variants
WO2022074037A2 (en) 2020-10-07 2022-04-14 Novozymes A/S Alpha-amylase variants
EP4291646A2 (en) 2021-02-12 2023-12-20 Novozymes A/S Alpha-amylase variants
CN112725316B (en) * 2021-03-04 2022-09-06 宁夏夏盛实业集团有限公司 Alkallikrein 2018 mutant and preparation method thereof
WO2022268885A1 (en) 2021-06-23 2022-12-29 Novozymes A/S Alpha-amylase polypeptides

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2219804A1 (en) * 1972-04-22 1973-10-31 Knapsack Ag Surfactants for dishwashing detergents
DE2727463A1 (en) * 1976-06-24 1978-01-05 Procter & Gamble DETERGENT PARTICULARLY SUITABLE FOR USE IN DISHWASHING MACHINES
GB2158087B (en) * 1984-05-04 1987-11-04 Procter & Gamble Non-caking detergent composition
EG18543A (en) * 1986-02-20 1993-07-30 Albright & Wilson Protected enzyme systems
IN168163B (en) * 1986-02-21 1991-02-16 Colgate Palmolive Co
US5039446A (en) * 1988-07-01 1991-08-13 Genencor International, Inc. Liquid detergent with stabilized enzyme
JP3220137B2 (en) 1989-08-25 2001-10-22 ヘンケル・リサーチ・コーポレイション Alkaline protease and method for producing the same
EP0599859A1 (en) * 1991-06-25 1994-06-08 Novo Nordisk A/S Mammalian pancreatic lipase and variant thereof
EP1921148B1 (en) 1994-02-24 2011-06-08 Henkel AG & Co. KGaA Improved enzymes and detergents containing them
EP0802968A1 (en) 1995-01-09 1997-10-29 Novo Nordisk A/S Stabilization of liquid enzyme compositions
BR9608857A (en) 1995-06-13 1999-06-15 Novo Nordisk As Liquid composition and liquid detergent
DK1303582T3 (en) 2000-07-22 2009-12-07 Genencor Int Stabilization of enzymes
MXPA04004479A (en) * 2001-11-13 2004-08-11 Procter & Gamble Topical compositions containing enzymes stabilized with inhibitors.
BE1014987A6 (en) * 2002-10-07 2004-07-06 Vandersteen Anne Marie Additive for liquid detergents for cleaning hard surfaces, including industrial and household surfaces, comprises a phosphate ester and a fluorosurfactant
WO2007113241A1 (en) 2006-03-31 2007-10-11 Novozymes A/S A stabilized liquid enzyme composition

Also Published As

Publication number Publication date
EP2220204A1 (en) 2010-08-25
US20100227789A1 (en) 2010-09-09
WO2009068501A1 (en) 2009-06-04
US8466098B2 (en) 2013-06-18
DE102007057583A1 (en) 2009-06-04

Similar Documents

Publication Publication Date Title
EP2220204B1 (en) Washing agent having stabilized enzymes
EP2115111B1 (en) Benzophenone or benzoic acid anilide derivatives containing carboxyl groups as enzyme stabilizers
EP3095860B1 (en) Storage-stable liquid washing or cleaning agent containing protease and amylase
EP2478097B1 (en) Stable liquid washing or cleaning agent containing a protease
EP3260537B1 (en) Storage-stable liquid washing or cleaning agent containing protease and cellulase
WO2009030632A1 (en) Polycyclic compounds as enzyme stabilizers
EP4143289A1 (en) Highly alkaline textile washing agent comprising protease
WO2013087545A1 (en) Storage-stable liquid detergent or cleaning agent containing protease and amylase
EP3067411A1 (en) Method for adapting a hydrolytic enzyme to a component stabilising the hydrolytic enzyme
EP2655587B1 (en) Liquid surfactant preparation containing lipase and phosphonate
EP3234088A1 (en) Liquid surfactant composition having special surfactant combination and enzyme
WO2021219297A1 (en) Highly alkaline textile detergent containing protease
EP3538632B1 (en) Detergent composition comprising amylase
WO2023232192A1 (en) Detergent and cleaning agent with improved enzyme stability
WO2023232193A1 (en) Detergents and cleaning agents with an improved enzyme stability
WO2023232194A1 (en) Detergents and cleaning agents with an improved enzyme stability
WO2016180659A1 (en) Enzyme stabilizers
EP2598622A2 (en) Stabilized liquid tenside preparation comprising enzymes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100330

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20120622

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20130701

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 646660

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140115

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502008011133

Country of ref document: DE

Effective date: 20140213

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140325

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20131225

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140425

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140428

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502008011133

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20140926

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502008011133

Country of ref document: DE

Effective date: 20140926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141130

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141124

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20141124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141130

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141130

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141124

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141124

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 646660

Country of ref document: AT

Kind code of ref document: T

Effective date: 20141124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140326

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20081124

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131225

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20171121

Year of fee payment: 10

Ref country code: FR

Payment date: 20171121

Year of fee payment: 10

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 502008011133

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181130

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190601